<SEC-DOCUMENT>0001104659-25-051610.txt : 20250521
<SEC-HEADER>0001104659-25-051610.hdr.sgml : 20250521
<ACCEPTANCE-DATETIME>20250521161401
ACCESSION NUMBER:		0001104659-25-051610
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250520
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250521
DATE AS OF CHANGE:		20250521

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Proto Labs Inc
		CENTRAL INDEX KEY:			0001443669
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED STRUCTURAL METAL PRODUCTS [3440]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35435
		FILM NUMBER:		25973285

	BUSINESS ADDRESS:	
		STREET 1:		5540 Pioneer Creek
		CITY:			Maple Plain
		STATE:			MN
		ZIP:			55359
		BUSINESS PHONE:		763-479-7474

	MAIL ADDRESS:	
		STREET 1:		5540 Pioneer Creek
		CITY:			Maple Plain
		STATE:			MN
		ZIP:			55359
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2515767d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:prlb="http://prlb.com/20250520">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_prlb_prlb.com_20250520 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20250520_20250520 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001443669 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000004" name="dei:EntityCentralIndexKey">0001443669</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prlb-20250520.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001443669</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-20</xbrli:startDate>
        <xbrli:endDate>2025-05-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20250520__20250520_zwdFI4piejyg"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90F_edei--DocumentPeriodEndDate_c20250520__20250520_z25BDWKkvVFb"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 20, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20250520__20250520_zwb0DdbXHSol"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000011" name="dei:EntityRegistrantName">Proto Labs, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="4" style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20250520__20250520_zLq8iKbzJtC3"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Minnesota</ix:nonNumeric></span></span></td>
    <td colspan="3" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="5" style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityFileNumber_c20250520__20250520_zLVyU3AmwsKe"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000013" name="dei:EntityFileNumber">001-35435</ix:nonNumeric></span></span></td>
    <td colspan="3" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="7" style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20250520__20250520_zQ2uMjBFrYmb"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000014" name="dei:EntityTaxIdentificationNumber">41-1939628</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td colspan="4" style="border-top: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction<br/>
of incorporation)</span></td>
    <td colspan="3" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="5" style="border-top: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td colspan="3" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="7" style="border-top: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer<br/>
Identification Number)</span></td></tr>
  <tr>
    <td colspan="3" style="padding: 0.75pt 1pt">&#160;</td>
    <td colspan="7" style="padding: 0.75pt 1pt">&#160;</td>
    <td colspan="5" style="padding: 0.75pt 1pt">&#160;</td>
    <td colspan="2" style="padding: 0.75pt 1pt">&#160;</td>
    <td style="padding: 0.75pt 1pt">&#160;</td>
    <td style="padding: 0.75pt 1pt">&#160;</td>
    <td style="padding: 0.75pt 1pt">&#160;</td>
    <td style="padding: 0.75pt 1pt">&#160;</td>
    <td style="padding: 0.75pt 1pt">&#160;</td></tr>
  <tr>
    <td colspan="15" style="padding: 1.5pt 1.25pt; vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20250520__20250520_zrIQi2tTC8o9"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000015" name="dei:EntityAddressAddressLine1">5540 Pioneer Creek Drive</ix:nonNumeric></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20250520__20250520_z6Ey2dxzZWal"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000016" name="dei:EntityAddressCityOrTown">Maple Plain</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20250520__20250520_zssvQb7yN897"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">Minnesota</ix:nonNumeric></span></p></td>
    <td colspan="4" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="3" style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityAddressPostalZipCode_c20250520__20250520_zOIGWvJkHt24"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000018" name="dei:EntityAddressPostalZipCode">55359</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td colspan="15" style="border-top: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td colspan="4" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="3" style="border-top: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  <tr>
    <td colspan="15" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="4" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="3" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td></tr>
  <tr>
    <td colspan="15" style="padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s telephone number, including area code:</span></td>
    <td colspan="4" style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; padding: 1.5pt 1.25pt; vertical-align: bottom; font-size: 10pt; text-align: center">(<span id="xdx_904_edei--CityAreaCode_c20250520__20250520_zZVgMRd3VPW6"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000019" name="dei:CityAreaCode">763</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20250520__20250520_zV6z35rMTSZc"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000020" name="dei:LocalPhoneNumber">479-3680</ix:nonNumeric></span></td></tr>
  <tr>
    <td colspan="8" style="padding: 0.75pt 1pt">&#160;</td>
    <td colspan="8" style="padding: 0.75pt 1pt">&#160;</td>
    <td colspan="6" style="padding: 0.75pt 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="22" style="padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not</span> Applicable</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="22" style="border-top: black 1pt solid; padding: 1.5pt 1.25pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former name or former address, if changed since last report)</span></td></tr>
  <tr>
    <td style="width: 10%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 10%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 14%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 6%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 6%"><span style="font-size: 1pt">&#160;</span></td>
    <td style="width: 6%"><span style="font-size: 1pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90D_edei--WrittenCommunications_c20250520__20250520_z4o9n5qtCcOe"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_907_edei--SolicitingMaterial_c20250520__20250520_z2fINk9hPSd8"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementTenderOffer_c20250520__20250520_z0uahTMseweh"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td></tr>
  <tr>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20250520__20250520_zXycEhQzGf8k"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding: 1.5pt 1.25pt; vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt 1.25pt 1.5pt 1.5pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt 1.25pt 1.5pt 1.5pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt 1.25pt 1.5pt 1.5pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20250520__20250520_znhhjO2lAmp6"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000025" name="dei:Security12bTitle">Common Stock, Par Value $0.001 Per Share</ix:nonNumeric></span></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt 1.25pt 1.5pt 1.5pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--TradingSymbol_c20250520__20250520_zohJc7qCg4wb"><ix:nonNumeric contextRef="AsOf2025-05-20" id="Fact000026" name="dei:TradingSymbol">PRLB</ix:nonNumeric></span></span></td>
    <td style="border: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SecurityExchangeName_c20250520__20250520_zczs9ePJSlx5"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Emerging growth company </span><span style="font-family: Wingdings"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20250520__20250520_zhwnOng23E1f"><ix:nonNumeric contextRef="AsOf2025-05-20" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 0.8in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.02.</b></span></td>
    <td style="text-align: justify; vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><span style="text-decoration: underline">Appointment of Mr.&#160;Krishna</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">On
May&#160;21, 2025, Proto Labs,&#160;Inc. (the &#8220;Company&#8221;) announced that the Board of Directors (the &#8220;Board&#8221;) of
the Company has appointed Suresh Krishna to serve as the Company&#8217;s President and Chief Executive Officer, effective May&#160;20,
2025 (the &#8220;Transition Date&#8221;), succeeding Robert Bodor, who ceased to be the President and Chief Executive Officer and a director
of the Company effective as of the Transition Date. The Board has also appointed Mr.&#160;Krishna to serve as a director of the Company,
filling the vacancy left on the Board by Dr.&#160;Bodor&#8217;s departure, until the earlier of the Company&#8217;s 2026 annual meeting
of shareholders and until his successor is elected and qualified, or until his earlier death, resignation, or removal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Suresh
Krishna, age 56, joined the Company from Northern Tool + Equipment, where he served as President and Chief Executive Officer from April&#160;2020
to November&#160;2024. Prior to joining Northern Tool + Equipment, Mr.&#160;Krishna served as the Senior Vice President and Chief Operations,
Supply Chain and Lean Officer of Sleep Number Corporation from April&#160;2016 to April&#160;2020. Mr.&#160;Krishna also served in various
leadership positions at Polaris Inc., including as Vice President and Business Unit Head of Europe Middle East&#160;&amp; Africa from
2014 to 2016 and Vice President of Global Operations and Integration from 2010 to 2014. From 2007 to 2010, he served at a division of
UTC Fire&#160;&amp; Security. Mr.&#160;Krishna also served in a variety of roles for Diageo, ABB and earlier in his career, he was an
associate at Booz Allen&#160;&amp; Hamilton.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with his appointment, Mr.&#160;Krishna entered into an Executive Employment Agreement with the Company, dated May&#160;20,
2025 (the &#8220;Employment Agreement&#8221;), which sets forth certain terms and conditions of his employment. </span>Pursuant to the
Employment Agreement, Mr.&#160;Krishna&#8217;s employment commenced as of the Transition Date and is for a term of three years, unless
earlier terminated, and will automatically be extended for successive one-year terms thereafter unless Mr.&#160;Krishna provides notice
of non-renewal. The Employment Agreement provides that Mr.&#160;Krishna will receive the following compensation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td><td style="text-align: justify">an initial annual base salary of $800,000;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">participation in the Company&#8217;s annual short-term incentive plan, with a target cash incentive bonus
equal to 100% of his base salary, with his payout for 2025 pro-rated&#160;based on the number of calendar days he is employed by the Company
from the Transition Date through December&#160;31, 2025;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">entitlement to participate in all employee benefit plans and programs generally available to executive
employees of the Company, as determined by the Company and to the extent he meets the eligibility requirements for each individual plan
or program; and</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the grant of the following equity awards, effective as of May&#160;23, 2025 (the &#8220;Grant Date&#8221;):</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td><td style="text-align: justify">$600,000 of restricted stock units (&#8220;RSUs&#8221;), which will vest as to 25% of the RSUs in four
annual installments beginning on the first anniversary of the Grant Date;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td><td style="text-align: justify">$600,000 of stock options (&#8220;Options&#8221;), with an exercise price equal to 100% of the closing
share price of the Company&#8217;s common stock on the Grant Date, and which will vest and become exercisable as to 25% of the shares
underlying the Options in four annual installments beginning on the first anniversary of the Grant Date and has a ten-year term;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td><td style="text-align: justify">$1,200,000 of performance stock units (&#8220;PSUs&#8221;), with the same terms and conditions as the
PSUs granted to the executive officers of the Company in February&#160;2025; and</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td><td style="text-align: justify">a one-time inducement award of $1,000,000 of PSUs, with the same terms and conditions as the PSUs granted
to the executive officers of the Company in February&#160;2025, plus a one-time inducement award of $1,000,000 of PSUs (the one-time PSU
awards collectively referred to as, the &#8220;Inducement Awards&#8221;) tied to certain revenue and total shareholder return metrics,
and other terms and conditions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The RSUs, Options, and PSUs
noted above will be granted under and pursuant to the Amended and Restated Proto Labs,&#160;Inc. 2022 Long-Term Incentive Plan (as amended,
the &#8220;2022 Plan&#8221;) and will be subject to the terms and conditions of the 2022 Plan and the forms of award agreements for such
types of awards previously approved by the Compensation and Talent Committee of the Board, <i>except for</i> the Inducement Awards, which
will be &#8220;inducement awards&#8221; within the meaning of the New York Stock Exchange Listed Company Manual Section&#160;303A.08 will
not be granted under the 2022 Plan, but they will have the same terms and conditions as equity awards granted under the 2022 Plan and
the award agreements for such types of awards, except as provided in the Inducement Award agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Employment Agreement provides
that if the Company terminates Mr.&#160;Krishna&#8217;s employment without cause (and other than as a result of Mr.&#160;Krishna&#8217;s
death or disability), or if Mr.&#160;Krishna&#8217;s resigns for good reason (either such event being a &#8220;Qualifying Termination&#8221;),
and provided that Mr.&#160;Krishna&#8217;s complies with certain conditions, including execution of a general waiver and release of claims
and compliance with the restrictive covenants agreement Mr.&#160;Krisha entered into in connection with entering into the Employment Agreement,
then Mr.&#160;Krishna will be entitled to certain benefits summarized below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Mr.&#160;Krishna has a
Qualifying Termination during the term of the Employment Agreement and not in connection with a change in control (which is the period
from the change in control until the 18-month period following a change in control (the &#8220;Change in Control Period&#8221;), then,
subject to certain conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay Mr.&#160;Krishna an amount equal to one times Mr.&#160;Krishna&#8217;s annualized
base salary in substantially equal installments in accordance with the Company&#8217;s regular payroll practices over the 12-month period
immediately following the termination date;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay Mr.&#160;Krishna a pro rata cash incentive bonus amount for the year in which the
termination occurs, payable in a lump sum&#894;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay its share of premiums due for Mr.&#160;Krishna and his eligible dependents for the
first 12 months of coverage under COBRA; and</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">if Mr.&#160;Krishna has any unvested equity-based awards as of the termination date, (i)&#160;a pro rata
portion of any time-based unvested awards scheduled to vest on the next anniversary of the grant date will vest immediately, determined
by multiplying the total number of additional shares that would otherwise have become exercisable or vested on the next anniversary of
the grant date had Mr.&#160;Krishna remained employed through that date by a fraction, the numerator of which is the number of days Mr.&#160;Krishna
was employed by the Company during the then current vesting year including the termination date and the denominator of which is 365 days;
and (ii)&#160;a pro rata portion of any performance-based awards will vest following the end of the performance period, determined by
multiplying the total number of additional shares that would otherwise have been determined to have been earned had Mr.&#160;Krishna remained
employed through the end of the applicable performance period by a fraction, the numerator of which is the number of days Mr.&#160;Krishna
was employed by the Company during the performance period and the denominator of which is the number of days in the performance period.
In the event that the terms of an equity award or the 2022 Plan provide more favorable treatment, the terms of such award or the 2022
Plan will control.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Mr.&#160;Krishna has a
Qualifying Termination which occurs within 90 days prior to a change in control, and if the termination arose in connection with or in
anticipation of the change in control, then, in addition to the compensation Mr.&#160;Krishna is entitled to receive in connection with
a Qualifying Termination which is not in connection with a change in control, as described above:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay Mr.&#160;Krishna an amount equal to one times Mr.&#160;Krishna&#8217;s annualized
base salary, payable in a lump sum;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay Mr.&#160;Krishna an amount equal to Mr.&#160;Krishna&#8217;s target annual cash incentive
bonus for the calendar year in which Mr.&#160;Krishna&#8217;s employment with the Company terminates, payable in a lump sum;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay its share of premiums due for Mr.&#160;Krishna and his eligible dependents for an
additional six months of coverage under COBRA; and</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay Mr.&#160;Krishna an amount equal to the intrinsic value of any unvested equity-based
awards held by him as of the termination date that were forfeited as of the termination date; in the case of forfeited performance-based
awards, the intrinsic value shall be based on the number of shares subject to an award based on a determination by the Board of the degree
to which any performance-based vesting or payment conditions will be deemed satisfied.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a change in control occurs
during the term of the Employment Agreement, and Mr.&#160;Krishna has a Qualifying Termination during the Change in Control Period, then,
subject to&#160;certain conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay Mr.&#160;Krishna an amount equal to two times Mr.&#160;Krishna&#8217;s annualized
base salary in substantially equal installments in accordance with the Company&#8217;s regular payroll practices over the 24-month period
immediately following the termination date;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay Mr.&#160;Krishna an amount equal to two times Mr.&#160;Krishna&#8217;s target annual
cash incentive bonus for the calendar year in which Mr.&#160;Krishna&#8217;s employment with the Company terminates, payable in a lump
sum;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the Company will pay its share of premiums due for Mr.&#160;Krishna and his eligible dependents for the
first 18 months of coverage under COBRA; and</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">all of Mr.&#160;Krishna&#8217;s unvested equity-based awards as of the termination date will vest immediately
on the termination date; in the case of performance-based awards, the number of shares subject to such accelerated vesting shall be based
on a determination by the Board of the degree to which any performance-based vesting conditions will be deemed satisfied.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the severance
pay and other benefits provided for in the Employment Agreement or otherwise payable to Mr.&#160;Krishna constitute &#8220;parachute payments&#8221;
under Section&#160;280G of the Internal Revenue Code and would be subject to excise taxes, then such benefits will either be delivered
in full or delivered as to such lesser extent which would result in no portion of such severance pay and other benefits being subject
to excise taxes, whichever results in the receipt by Mr.&#160;Krishna of the greatest amount of benefits on an after-tax basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment
Agreement as set forth in Exhibit&#160;10.1 to this Current Report on Form&#160;8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no arrangements
or understandings between Mr.&#160;Krishna and any other persons pursuant to which Mr.&#160;Krishna was selected as an officer or director
of the Company, Mr.&#160;Krishna has no family relationships with any of the Company&#8217;s directors or executive officers, and Mr.&#160;Krishna
is not a party to and does not have any direct or indirect material interest in any transaction requiring disclosure&#160;under&#160;Item
404(a)&#160;of&#160;Regulation S-K&#160;under&#160;the&#160;Securities Act of 1933, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><span style="text-decoration: underline">Departure of Dr.&#160;Bodor</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As disclosed above, Dr.&#160;Bodor
departed the Company, effective as of the Transition Date, and ceased to be an employee and director of the Company as of such date. While
Dr.&#160;Bodor resigned from the Company, the Company agreed to provide the severance compensation contemplated by the provisions for
a termination without cause or a resignation for good reason under Section&#160;7.A.(i)&#160;of his Executive Employment Agreement, dated
January&#160;29, 2021, a copy of which was previously filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;)
and is incorporated herein by reference as Exhibit&#160;10.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Dr.&#160;Bodor and the Company entered into a Consulting Agreement, dated May&#160;20, 2025 (the &#8220;Consulting Agreement&#8221;),
pursuant to which Dr.&#160;Bodor agreed to provide services </span>to support the transition of management through May&#160;25, 2025.
In exchange for his services, the Company will pay Dr.&#160;Bodor a fee of $700 per hour. The Company and Dr. Bodor are also discussing the possibility of Dr. Bodor providing consulting services for a longer period of time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Consulting
Agreement as set forth in Exhibit&#160;10.3 to this Current Report on Form&#160;8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Amendment to the 2022 Plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As reported below in Item
5.07, on May&#160;20, 2025, the shareholders of the Company approved the amendment to the 2022 Plan, which increased the number of shares
available for issuance pursuant to awards under the plan by an additional 296,000 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A description of the 2022
Plan was included in the Company&#8217;s proxy statement for its annual meeting of shareholders filed with the Commission on <span style="background-color: white">April&#160;9,
2025, and a</span> copy of the 2022 Plan, as amended, is filed hereto as Exhibit&#160;10.4 and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 0.8in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.07.</b></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Submission of Matters to a Vote of Security Holders.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company held its Annual
Meeting of Shareholders on May&#160;20, 2025 (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the Company&#8217;s shareholders
elected all eight persons nominated by the Board. All eight directors will serve as directors until the next Annual Meeting of Shareholders
or until their successors are elected and duly qualified, other than Dr.&#160;Bodor, who ceased to be a director as of the Transition
Date as disclosed above in Item 5.02. The Company&#8217;s shareholders also ratified the selection of Ernst&#160;&amp; Young LLP as the
Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2025, approved an advisory
vote on the compensation of the Company&#8217;s executive officers and approved the amendment to the 2022 Plan. Set forth below are the
final voting results for each of the proposals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Proposal 1. Election of Directors.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">Name</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Against</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Broker Non-Votes</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: left">Robert Bodor</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">18,568,998</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">262,158</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">3,137</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">2,109,195</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Archie C. Black</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">15,494,829</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,334,912</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">4,552</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,109,195</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sujeet Chand</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">17,551,583</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,276,833</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">5,877</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,109,195</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Moonhie Chin</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">16,132,849</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,695,787</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">5,657</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,109,195</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Rainer Gawlick</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">18,211,102</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">618,665</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">4,526</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,109,195</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stacy Greiner</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">18,590,462</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">239,096</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">4,735</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,109,195</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Donald G. Krantz</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">16,205,392</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,624,410</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">4,491</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,109,195</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sven A. Wehrwein</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">17,721,917</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,107,016</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">5,360</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,109,195</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Proposal 2. Ratification of the selection of Ernst&#160;&amp; Young
LLP as the independent registered public accounting firm for the fiscal year ending December&#160;31, 2025.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Against</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Broker Non-Votes</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center">20,722,129</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">212,208</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">9,151</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">&#8212;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Proposal 3. Advisory approval of executive compensation.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Against</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Broker Non-Votes</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center">16,067,528</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">2,756,966</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">9,799</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">2,109,195</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Proposal 4. Approval of the amendment to the Amended and Restated
Proto Labs,&#160;Inc. 2022 Long-Term Incentive Plan.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Against</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Broker Non-Votes</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center">18,175,924</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">649,673</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">8,696</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: center">2,109,195</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 0.8in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 7.01.</b></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation FD Disclosure</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;21, 2025, the
Company issued a press release announcing the leadership transition described in Item 5.02&#160;above. A copy of the press release is
attached hereto as Exhibit&#160;99.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">In
accordance with&#160;</span>General&#160;<span style="color: #212529">Instruction B.2 of Form&#160;8-K, the information in this Item 7.01,
including Exhibit&#160;99.1, shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange
Act of 1934 or otherwise subject to the&#160;</span>liability<span style="color: #212529">&#160;of that section, and shall not be incorporated
by reference into any registration statement or other document filed under the&#160;Securities Act of 1933&#160;or the&#160;Securities
Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.8in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01.</b></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><b>(d)</b></td><td><b>Exhibits</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 11%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Exhibit&#160;No.</b></p></td>
    <td style="vertical-align: bottom; width: 87%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    </tr>
  <tr>
    <td style="border-top: black 1pt solid; font-size: 10pt"><a href="tm2515767d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="border-top: black 1pt solid; vertical-align: bottom; font-size: 10pt"><a href="tm2515767d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Employment Agreement, dated May&#160;20, 2025, by and between Proto Labs,&#160;Inc. and Suresh Krishna</span></a></td>
    </tr>
  <tr>
    <td style="font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1443669/000143774921002024/ex_224239.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td style="text-align: justify; vertical-align: bottom; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1443669/000143774921002024/ex_224239.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Employment Agreement, dated January&#160;29, 2021, by and between Proto Labs,&#160;Inc. and Robert Bodor (incorporated by reference to Exhibit&#160;10.1 to the Company&#8217;s Form&#160;8-K, filed on February&#160;4, 2021)</span></a></td>
    </tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2515767d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></a></td>
    <td style="vertical-align: bottom; font-size: 10pt"><a href="tm2515767d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated May&#160;20, 2025, by and between Proto Labs,&#160;Inc. and Robert Bodor</span></a></td>
    </tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2515767d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></a></td>
    <td style="vertical-align: bottom; font-size: 10pt"><a href="tm2515767d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Proto Labs,&#160;Inc. 2022 Long-Term Incentive Plan, as amended May&#160;20, 2025</span></a></td>
    </tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2515767d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom; font-size: 10pt"><a href="tm2515767d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated May&#160;21, 2025</span></a></td>
    </tr>
  <tr>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proto Labs,&#160;Inc.</span></td>
    </tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="font-size: 10pt">
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</span></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&#160;21,
    2025</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Daniel Schumacher</span></td>
    </tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel
    Schumacher</span></td>
    </tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNoNJrJHxxRxigwRX6vLpLg1I626fZJ/ad0QQyAk955cISZiTStdI8N5WeRwxKatlUMosEJGc0XvSDfbBPws8KatY2XcsP7AlDyDnplP5cXfB+dTWywTkPEskrMoBrlI4gUcdiL46imZSpdonFY1KFPCgalljU5xP344qo4MNf2QdEK2mkwC4VSO8hsiGUawp6d6Ed8t5HkqgslQgVgzPVrvyjqH5ktCVmPj4+xI/zv4AM9FSmM= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2515767d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROTO LABS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXECUTIVE EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <FONT STYLE="font-variant: small-caps"><B>Executive
Employment Agreement</B></FONT> (the &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into as of May&nbsp;20, 2025 (the &ldquo;<B><I>Effective
Date</I></B>&rdquo;) by and between <FONT STYLE="font-variant: small-caps"><B>Proto Labs,&nbsp;Inc.,</B></FONT> a Minnesota corporation
(the &ldquo;<B><I>Company</I></B>&rdquo;), and Suresh Krishna (&ldquo;<B><I>Executive</I></B>&rdquo;), an individual residing in Minnesota.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Recitals</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company desires to employ Executive, and Executive desires to be employed by the Company, in accordance with the terms and conditions
stated in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;During
employment with the Company, Executive will have access to confidential, proprietary and trade secret information of the Company. It is
desirable and in the best interests of the Company to protect confidential, proprietary and trade secret information of the Company, to
prevent unfair competition by former executives of the Company following separation of their employment with the Company and to secure
cooperation from former executives with respect to matters related to their employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
understands that Executive&rsquo;s employment and receipt of the compensation and benefits provided for in this Agreement depends on,
among other things, Executive&rsquo;s willingness to agree to abide by the non-disclosure, non-solicitation, assignment of inventions
and other covenants contained in an Employee Confidentiality,&nbsp;Intellectual Property Assignment and Non-Solicitation Agreement, dated
as of the Effective Date (the &ldquo;<B><I>Restrictive Covenants Agreement</I></B>&rdquo;), attached as Exhibit&nbsp;A to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;It
is desirable and in the best interests of the Company and its shareholders to obtain the benefits of Executive&rsquo;s services and attention
to the affairs of the Company and to identify certain severance payments and benefits in the event that Executive is separated from employment
with the Company under certain identified circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
the reasons set forth above, the Company and Executive desire to enter into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Now,
Therefore</B></FONT>, in consideration of the foregoing and the mutual covenants set forth herein, the Company and Executive, intending
to be legally bound, hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Term.</B></FONT>
Executive&rsquo;s employment pursuant to the terms of this Agreement shall commence on May&nbsp;20, 2025 (the &ldquo;<B><I>Start Date</I></B>&rdquo;)
and expire on May&nbsp;19, 2028 (the &ldquo;<B><I>Expiration Date</I></B>&rdquo;), unless Executive&rsquo;s employment is terminated at
an earlier date in accordance with Section&nbsp;6. The period between the Effective Date and the Expiration Date is referred to herein
as the &ldquo;<B><I>Initial Term</I></B>.&rdquo; Effective as of the Expiration Date and each successive one year anniversary of the Effective
Date (each an &ldquo;<B><I>Anniversary Date</I></B>&rdquo;), the term shall be automatically extended until the subsequent Anniversary
Date (each a &ldquo;<B><I>Renewal Term</I></B>&rdquo;) unless Executive gives written notice of non-renewal to the Company at least sixty
(60) days prior to the Anniversary Date on which this Agreement would otherwise be automatically extended that Executive elects not to
extend the term. The Initial Term, together with any Renewal Terms, is the &ldquo;<B><I>Term</I></B>.&rdquo; If Executive remains employed
by the Company after the Term, then Executive shall no longer be entitled to any severance payments or benefits under this Agreement and
any severance rights Executive may have shall be according to the terms and conditions established by the Company from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Employment
and Duties.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.&#8239;&#8239;&#8239;&#8239;&#8239;Position
and Responsibilities.</B></FONT>&nbsp;During the Term Executive shall serve as the Company&rsquo;s President, Chief Executive Officer
and shall perform such duties of an executive nature as the Company&rsquo;s Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;)
may assign from time to time. Executive will follow and comply with applicable policies and procedures adopted by the Company from time
to time, including without limitation policies relating to business ethics, conflict of interest, non-discrimination, confidentiality
and protection of trade secrets, and insider trading. Executive shall devote Executive&rsquo;s full working time and efforts to the Company&rsquo;s
business, to the exclusion of all other employment or active participation in other material business interests, unless otherwise consented
to in writing by the disinterested members of the Board. Executive may not serve as a director on any other board of directors without
the written consent of the Board. Executive hereby represents and confirms that Executive is under no contractual or legal commitments
that Executive believes would prevent Executive from fulfilling Executive&rsquo;s duties and responsibilities as set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.&#8239;&#8239;&#8239;&#8239;&#8239;Board
Appointment.</B></FONT>&#8239;&#8239;&#8239;&#8239;Within five (5)&nbsp;business days after the Start Date the Board shall appoint Executive
as a director of the Company and the Board shall nominate Executive for re-election to the Board at each meeting of shareholders at which
directors will be elected during the Term. Executive acknowledges and agrees that Executive is not entitled to any additional compensation
in respect of Executive&rsquo;s appointment as a director of the Company.&nbsp; If during the Term Executive ceases to be a director of
the Company for any reason, Executive&rsquo;s employment with the Company will continue (unless terminated in accordance with Section&nbsp;6)
and all terms of this Agreement (other than those relating to Executive&rsquo;s position as a director of the Company) will continue in
full force and effect.<I>&nbsp;</I>Executive agrees to abide by all statutory, fiduciary or common law duties arising under applicable
law that apply to Executive as a director of the Company.&nbsp; Executive further agrees that Executive will not resign as a director
of the Company without the prior written consent of the Board and if Executive so resigns or if Executive is disqualified from acting
as a director of the Company, then the Company may at its discretion terminate Executive&rsquo;s employment under this Agreement for Cause
(as defined in Section&nbsp;6.D.).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>At
Will Employment. </B>Executive&rsquo;s employment with the Company shall be at will and Executive&rsquo;s employment may be unilaterally
terminated by either party at any time for any reason, subject to the terms of Sections 6 and 7 of this Agreement. The effective date
of Executive&rsquo;s termination of employment with the Company and its affiliates is referred to herein as the &ldquo;<B><I>Termination
Date</I></B>.&rdquo; For purposes of Section&nbsp;7 only, with respect to the timing of any severance payments or benefits thereunder,
the Termination Date means the date on which a &ldquo;separation from service&rdquo; has occurred for purposes of Section&nbsp;409A of
the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (the &ldquo;<B><I>Code</I></B>&rdquo;). Unless
otherwise requested by the Board in writing, upon Executive&rsquo;s termination of employment with the Company for any reason Executive
will automatically resign as of the Termination Date from all non-employee titles, positions and appointments Executive then holds with
the Company, whether as an officer, director or trustee (without any claim for compensation related thereto), and Executive hereby agrees
to take all actions necessary to effectuate such resignations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Compensation,
Benefits and Expenses. </B></FONT>While employed by the Company during the Term, Executive will be provided with the following compensation
and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.&#8239;&#8239;&#8239;&#8239;&#8239;Base
Salary.</B></FONT>&nbsp;The Company will pay to Executive for services provided hereunder after the Start Date a base salary at the annualized
rate of $800,000.00, which base salary will be paid in accordance with the Company&rsquo;s normal payroll policies and procedures (&ldquo;<B><I>Base
Salary</I></B>&rdquo;).&nbsp; Consistent with the charter of the Compensation and Talent Committee of the Board (the<I>&nbsp;</I>&ldquo;<B><I>Compensation
Committee</I></B>&rdquo;) and the Company&rsquo;s Corporate Governance Guidelines, the independent directors will evaluate Executive&rsquo;s
performance on an annual basis and then the Compensation Committee will review this evaluation and determine any adjustments to Executive&rsquo;s
Base Salary, subject to ratification by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.&#8239;&#8239;&#8239;&#8239;&#8239;Annual
Cash Incentive Bonus.</B></FONT>&nbsp;Executive will be eligible for an annual target cash incentive bonus equal to one hundred percent
(100 %) of Executive&rsquo;s then-current Base Salary (the &ldquo;<B><I>Annual Bonus</I></B>&rdquo;), based on achievement of objectives
as determined by the Company, payable no later than March&nbsp;15 of the calendar year following the calendar year for which the bonus
was earned. For 2025, Executive&rsquo;s payout will be&nbsp;pro-rated&nbsp;based on the number of calendar days he is employed by the
Company from the Start Date through December&nbsp;31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.&#8239;&#8239;&#8239;&#8239;&#8239;Employee
Benefits.</B></FONT>&nbsp;Executive will be entitled to participate in all employee benefit plans and programs generally available to
executive employees of the Company, as determined by the Company and to the extent that Executive meets the eligibility requirements for
each individual plan or program. Executive&rsquo;s participation in any plan or program will be subject to the provisions, rules, and
regulations of, or applicable to, the plan or program. The Company provides no assurance as to the adoption or continuation of any particular
employee benefit plan or program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.&#8239;&#8239;&#8239;&#8239;&#8239;Expenses.</B></FONT>&nbsp;The
Company will reimburse Executive for all reasonable and necessary out-of-pocket business, travel, and entertainment expenses incurred
by Executive in the performance of Executive&rsquo;s duties and responsibilities to the Company during the Term. Such reimbursement shall
be subject to the Company&rsquo;s normal policies and procedures for expense verification, documentation, and reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Initial
Equity&nbsp;Awards.</B></FONT>&nbsp; On the earliest day permitted pursuant to the terms of the Company&rsquo;s Equity Award Approval
Policy following commencement of the Term (the &ldquo;<B><I>Grant Date</I></B>&rdquo;), Executive will receive the equity awards set forth
below, with the dollar values converted to numbers of shares underlying the equity awards based on the stock value on the Grant Date.
These equity awards will be subject to the terms and conditions of the applicable award agreements between the Company and Executive dated
effective as of the Grant Date (the &ldquo;<B><I>Award Agreements</I></B>&rdquo;), including such terms and conditions as are incorporated
from the Company&rsquo;s Amended and Restated 2022 Long-Term Incentive Plan (as amended from time to time, the &ldquo;<B><I>Plan</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>2025
Equity Award: $2,400,000 granted in the form of 25% restricted stock units (&ldquo;<B><I>RSUs</I></B>&rdquo;), 25% stock options, and
50% performance stock units (&ldquo;<B><I>PSUs</I></B>&rdquo;), each with the same terms and conditions as such equity awards granted
to the executive officers of the Company in February&nbsp;2025, and the vesting dates of the RSUs and the stock options shall be based
on the anniversaries of the Grant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>Sign-On
Inducement Award: $2,000,000 granted in the form of PSUs, (A)&nbsp;50% of which will be based on the same terms and conditions as the
PSUs granted to the executive officers of the Company in February&nbsp;2025 (&ldquo;<B><I>2025 PSU Criteria</I></B>&rdquo;), and (B)&nbsp;50%
of which will first be subject to revenue-related goals established by the Compensation Committee for two performance periods, July&nbsp;1,
2025 &ndash; December&nbsp;31, 2025 and January&nbsp;1, 2026 &ndash; June&nbsp;30, 2026, and following the determination of the number
of such PSUs achieved under those goals, such number of PSUs shall become the target number of PSUs that may be earned pursuant to the
2025 PSU Criteria. These PSUs will be granted under the inducement grant exception to the New York Stock Exchange listing rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.&#8239;&#8239;&#8239;&#8239;&#8239;Annual
Equity.</B></FONT>&nbsp;Beginning in 2026, Executive shall receive an annual equity grant based on terms and conditions that are comparable
to those applicable to grants made to other senior executives of the Company, including achievement of personal or Company objectives
established by the Board or the Compensation Committee, and on such other terms applicable to other executives as are established by the
Board or the Compensation Committee in its reasonable discretion (&ldquo;<B><I>Annual Equity</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Restrictive
Covenants Agreement. </B></FONT>Executive acknowledges entering into the Restrictive Covenants Agreement as a condition of Executive&rsquo;s
employment with the Company and the Company entering into this Agreement and hereby acknowledges and confirms Executive&rsquo;s commitments
and obligations under the Restrictive Covenants Agreement. Nothing in this Agreement is intended to modify, amend, cancel or supersede
the Restrictive Covenants Agreement in any manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Termination.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Termination
of Employment. </B>Except as provided in Sections 6.B., C., D. and E., each party hereto may terminate Executive&rsquo;s employment by
giving to the other party no less than thirty (30) days prior written notice of the party&rsquo;s intent to terminate. If Executive voluntarily
terminates Executive&rsquo;s employment without Good Reason or the Company terminates the Executive&rsquo;s employment for Cause, then
the Company shall have no further liability to Executive for any payment, compensation or benefit whatsoever, other than payment of Executive&rsquo;s
earned but unpaid salary, cash incentive bonus and benefits through the Termination Date and honoring Executive&rsquo;s rights under the
Award Agreements or under any other restricted stock, stock options, stock units or other equity agreement between Executive and the Company
(collectively, &ldquo;<B><I>Equity Awards</I></B>&rdquo;). If the Company terminates Executive&rsquo;s employment without Cause (as set
forth in Section&nbsp;6.D.) and other than as a result of death or Disability (as set forth in Section&nbsp;6.C.), or if Executive terminates
Executive&rsquo;s employment for Good Reason (as set forth in Section&nbsp;6.E.) (either such event being a &ldquo;<B><I>Qualifying Termination</I></B>&rdquo;),
and subject to Executive&rsquo;s compliance with Section&nbsp;7 of this Agreement and with the Restrictive Covenants Agreement, then Executive
shall be entitled to severance payments and benefits as described in and pursuant to the terms and conditions of Section&nbsp;7 of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>By
Death. </B>Executive&rsquo;s employment shall be terminated automatically upon the death of Executive. The Company&rsquo;s total liability
in such event shall be limited to payment of Executive&rsquo;s earned but unpaid salary, cash incentive bonus and benefits through the
date of Executive&rsquo;s death and honoring Executive&rsquo;s rights under any Equity Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>By
Disability. </B>The Company may terminate Executive&rsquo;s employment upon the inability of Executive to perform on a full-time basis
the duties and responsibilities of Executive&rsquo;s employment with the Company, after any reasonable accommodation that may be required
under applicable law is made by the Company, by reason of Executive&rsquo;s illness or other physical or mental impairment or condition,
if such inability continues for an uninterrupted period of one hundred and twenty (120) days (a &ldquo;<B><I>Disability</I></B>&rdquo;).
A period of inability shall be &ldquo;uninterrupted&rdquo; unless and until Executive returns to full-time work for a continuous period
of at least thirty (30) days. The Company shall have no liability for severance pay or benefits following any Termination Date due to
Disability, other than payment of Executive&rsquo;s earned but unpaid salary, cash incentive bonus and benefits through the Termination
Date, honoring Executive&rsquo;s rights under any Equity Awards, and any rights Executive has to disability insurance benefits under applicable
law or the Company&rsquo;s short or long term disability insurance policies as in effect at the time of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>For
Cause. </B>The employment relationship between Executive and the Company created hereunder shall automatically and immediately terminate
upon receipt by Executive of notice of termination for Cause after the occurrence of any one of the events set forth below, each of which
will be considered &ldquo;<B><I>Cause</I></B>&rdquo; for termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>Executive&rsquo;s
intentional and knowing failure or refusal to perform satisfactorily the material duties reasonably required of Executive by the Board
(other than by reason of Disability);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>Executive&rsquo;s
material and knowing violation of any law, rule, regulation, court order or regulatory directive (other than traffic violations, misdemeanors
or other minor offenses);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>Executive&rsquo;s
material breach of the Restrictive Covenants Agreement or any Company code of conduct;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>Executive
engaging in any act or practice that involves personal dishonesty on the part of Executive or demonstrates a willful and continuing disregard
for the best interests of the Company or its affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>Any
of the events triggering the Company&rsquo;s right to terminate that are described in the last sentence of Section&nbsp;2.B. of this Agreement;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>While
performing corporate duties and responsibilities, Executive engaging in conduct that would be reasonably expected to harm or bring disrepute
to the Company, any of its affiliates, or any of their customers, employees or vendors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Good
Reason. </B>Executive&rsquo;s voluntary resignation of Executive&rsquo;s employment under this Agreement will be considered to be with
 &ldquo;<B><I>Good Reason</I></B>&rdquo; if, following the occurrence of one or more of the events listed below, (1)&nbsp;Executive provides
written notice to the Board of the event(s)&nbsp;constituting Good Reason within sixty (60) days after the first occurrence of such event(s),
(2)&nbsp;the Company fails to reasonably cure such event(s)&nbsp;within thirty (30) days after receiving such notice, and (3)&nbsp;the
Termination Date is not later than thirty (30) days after the end of the period in which the Board may cure the event(s). For the avoidance
of doubt, Executive will not be entitled to any compensation or benefits pursuant to this Agreement if Executive voluntarily resigns from
Executive&rsquo;s employment without Good Reason. The following events will give rise to Good Reason, unless Executive has consented thereto
in writing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>a
material reduction in Executive&rsquo;s annual compensation, which is comprised of Base Salary, target Annual Bonus, and Annual Equity
award amount, other than a reduction of Base Salary, target Annual Bonus, or Annual Equity award amount that is part of and proportionally
consistent with a broad-based reduction of Base Salary, target Annual Bonus, or Annual Equity award amount applicable to the Company&rsquo;s
senior executives (provided, however, that any reduction in Executive&rsquo;s Base Salary below $800,000.00 for any year during the Term
without Executive&rsquo;s consent will constitute a material reduction for purposes of this Good Reason definition);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>a
material diminution in Executive&rsquo;s authority, duties or responsibilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>the
Company removing Executive from the Board or failing to renominate Executive to serve on the Board other than in connection with the Company
terminating Executive for Cause or because Executive is disqualified from acting as a director of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>a
change in the location of the Company facility or office where Executive is based to a location more than fifty (50) miles from the Company
facility or office where Executive is based as of the Start Date; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT>a
material breach by the Company of any terms or conditions of this Agreement or any other agreement between Executive and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Severance.
</B></FONT>If there is a Qualifying Termination, provided that Executive&rsquo;s termination of employment constitutes an involuntary
 &ldquo;separation from service&rdquo; (a &ldquo;<B><I>Separation from Service</I></B>&rdquo;) under Section&nbsp;409A of the Code (&ldquo;<B><I>Section&nbsp;409A</I></B>&rdquo;),
and provided that Executive signs, within forty-five (45) days after the Separation from Service, and does not rescind a general waiver
and release of claims in favor of the Company and its affiliates in a form to be prescribed by the Company (with such release carving
out typical post-termination matters from such release, including but not limited to any severance obligations and vested rights of Executive
and/or obligations of the Company to indemnify Executive for claims arising out of or related to service as an officer or director of
the Company), and provided further that Executive is in compliance with Executive&rsquo;s continuing obligations to the Company (including
but not limited to those in the Restrictive Covenants Agreement), then Executive will receive the severance payments and benefits identified
in this Section&nbsp;7. If Executive becomes eligible to receive any severance payments or benefits under this Section&nbsp;7, then Executive
will not be eligible to receive any severance payments or benefits under any other agreement between Executive and the Company or under
any severance plan or program adopted by the Company. Notwithstanding any provisions in this Agreement to the contrary, this Agreement
will not provide duplicate benefits with any severance plan or program adopted by the Company (&ldquo;<B><I>Other Severance Plan</I></B>&rdquo;).
Executive will receive severance benefits, if any, pursuant to this Agreement, and not under any Other Severance Plan, which will not
apply to Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Payments
Upon Qualifying Termination Prior to a Change in Control or After the Expiration of the Transition Period.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Qualifying
Termination (Other than During the Transition Period). </B>If the Termination Date occurs during the Term and is prior to any Change in
Control (as defined below) or after the Transition Period (as defined below), and if such termination is a Qualifying Termination, then,
in addition to such base salary, cash incentive bonus and benefits that have been earned but not paid to Executive as of the Termination
Date, and subject to Executive satisfying the conditions identified in the first paragraph of this Section&nbsp;7, the Company shall provide
to Executive the following severance payments and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Base
Salary Cash Severance.</B></FONT> The Company shall pay to Executive an amount equal to one (1)&nbsp;times Executive&rsquo;s annualized
Base Salary as of the Termination Date (or, if Executive&rsquo;s resignation is for Good Reason because the Company materially reduced
Executive&rsquo;s Base Salary, one (1)&nbsp;times Executive&rsquo;s annualized Base Salary as of immediately before such material reduction),
less deductions and withholding required by law, payable in substantially equal installments in accordance with the Company&rsquo;s regular
payroll practices over the 12-month period immediately following the Termination Date; provided, however that any installments that otherwise
would be payable within the 60-day period immediately following the Termination Date shall be delayed and payable with the installment
that is payable on the Company&rsquo;s first payroll date following the 60th day after the Termination Date. Notwithstanding anything
above to the contrary, to the extent that the amount paid under the first sentence of this Section&nbsp;7.A.(i)(a)&nbsp;exceeds the lesser
of two times (I)&nbsp;the limit of compensation set forth in section 401(a)(17) of the Code as in effect for the year in which the Termination
Date occurs, or (II)&nbsp;Executive&rsquo;s annualized compensation based upon the annual rate of pay for services to the Company for
the calendar year prior to the calendar year in which the Termination Date occurs (adjusted for any increase during that year that was
expected to continue indefinitely if Executive had not separated from service), then the Company shall make an additional separate lump
sum payment to Executive equal to the excess amount. Such lump sum payment shall be a separate payment from the installment payments provided
under this Section&nbsp;7.A.(i)(a)&nbsp;and shall be paid to Executive on the Company&rsquo;s first payroll date following the 60th day
after the Termination Date but in no event later than two and one-half (2 &frac12;) months after the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Pro
Rata Bonus Payment.</B> The Company shall pay to Executive a pro rata cash incentive bonus amount calculated by multiplying the annual
cash incentive bonus Executive would have received under the Company&rsquo;s annual cash incentive bonus plan for the calendar year in
which the Termination Date occurs assuming Executive would have remained employed through the date Executive would have otherwise earned
an annual cash incentive bonus under such year&rsquo;s annual cash incentive bonus plan by a fraction, the numerator of which is the number
of days Executive was employed by the Company during the calendar year in which the Termination Date occurs through and including the
Termination Date and the denominator is 365, less deductions and withholding required by law, payable in a lump sum at the same time as
other eligible employees under the Company&rsquo;s annual cash incentive bonus plan for such calendar year are paid their bonuses under
such Company&rsquo;s annual cash incentive bonus plan for such calendar year, but in any event no later than March&nbsp;15 of the calendar
year immediately following the calendar year in which the Termination Date occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Benefits
Continuation.</B></FONT> If Executive was enrolled in a group health plan (<I>e.g.</I>, medical, dental, or vision plan) sponsored by
the Company immediately prior to the Termination Date, and if Executive (or Executive&rsquo;s eligible dependents) timely elects to continue
such coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (together with any state law of similar effect, &ldquo;<B><I>COBRA</I></B>&rdquo;),
then the Company will pay to the insurance carrier(s)&nbsp;its share of the premiums due for Executive and Executive&rsquo;s eligible
dependents for the first twelve (12) months of such coverage under COBRA (or until such earlier time as Executive and/or Executive&rsquo;s
eligible dependents are no longer eligible for COBRA coverage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Vesting
of Equity Awards. </B></FONT>The Equity Awards shall be governed by their terms; however, the following provisions shall apply to the
extent that they provide more favorable terms to the Executive than the terms set forth in the Equity Awards or in the Plan: if Executive
has an unvested option to purchase Shares (as defined in the Plan) or any unvested Stock Units (as defined in the Plan) under any Equity
Award under the Plan addressing Executive&rsquo;s option to purchase or right or have vest Shares, then a pro rata portion of any such
time-based award scheduled to vest on the next anniversary of the grant date for such award will vest as of the Termination Date and a
pro rata portion of any such performance-based award will vest as provided below. In the case of time-based awards, the number of additional
Shares that Executive will have the option to purchase or will have vest as a result of such pro rata vesting will be determined by multiplying
the total number of additional Shares Executive would have had the option to purchase, or have had vest, as of the next anniversary of
the grant date for such award assuming Executive would have remained employed through such anniversary by a fraction, the numerator of
which is the number of days Executive was employed by the Company during the then-current vesting year through and including the Termination
Date and the denominator is 365. For performance-based awards, the number of additional Shares that Executive will have vest as a result
of such pro rata vesting will be determined by multiplying the total number of additional Shares that would otherwise have been determined
to have been earned had Executive remained employed through the end of the applicable performance period by a fraction, the numerator
of which is the number of days Executive was employed by the Company during the performance period and the denominator is the number of
days in the performance period (<I>e.g.</I>, 1,095 days in the case of a three-year performance period). Performance-based awards will
be settled within two and one-half (2 &frac12;) months after the last day of the relevant performance period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&#8239;&#8239;&#8239;&#8239;&#8239;Other
Termination (Other Than During the Transition Period).</B></FONT>&nbsp;If the Termination Date occurs for any reason after expiration
of the Term (subject to Section&nbsp;7.C.), or if the Termination Date occurs during the Term and is prior to any Change in Control or
after the Transition Period for any of the following reasons: (a)&nbsp;Executive&rsquo;s abandonment of or resignation from employment
for any reason other than Good Reason; (b)&nbsp;termination of Executive&rsquo;s employment by the Company for Cause; or (c)&nbsp;due
to Executive&rsquo;s death or Disability, then the Company shall pay to Executive, or Executive&rsquo;s beneficiary or estate, as the
case may be, such base salary, bonus and benefits (including Annual Bonus) that have been earned but not paid to Executive as of the Termination
Date, payable pursuant to the Company&rsquo;s normal payroll practices and procedures and to the extent and in the manner provided in
any applicable plans or programs, pay any additional amount that may be payable under Section&nbsp;6.B. Section&nbsp;6.C. (as applicable)
and honor Executive&rsquo;s rights under any Equity Awards, and Executive shall not be entitled to any additional compensation or benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payments
Upon Termination During the Transition Period.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Qualifying
Termination During the Transition Period. </B>If a Change in Control occurs during the Term and Executive&rsquo;s Termination Date occurs
on the date of the Change in Control or prior to the 18-month anniversary of the Change in Control (such 18-month period, the &ldquo;<B><I>Transition
Period</I></B>&rdquo;), and if such termination is a Qualifying Termination, then, in addition to such base salary, cash incentive bonus
and benefits that have been earned but not paid to Executive as of the Termination Date, and subject to Executive satisfying the conditions
identified in the first paragraph of this Section&nbsp;7, the Company shall provide to Executive the following severance payments and
benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Base
Salary Cash Severance.</B></FONT> The Company shall pay to Executive an amount equal to two (2)&nbsp;times Executive&rsquo;s annualized
Base Salary as of the Termination Date (or, if Executive&rsquo;s resignation is for Good Reason because the Company materially reduced
Executive&rsquo;s Base Salary, two (2)&nbsp;times Executive&rsquo;s annualized Base Salary as of immediately before such material reduction),
less deductions and withholding required by law, payable in substantially equal installments in accordance with the Company&rsquo;s regular
payroll practices over the 24-month period immediately following the Termination Date; provided, however that any installments that otherwise
would be payable within the 60-day period immediately following the Termination Date shall be delayed and payable with the installment
that is payable on the Company&rsquo;s first payroll date following the 60th day after the Termination Date. Notwithstanding anything
above to the contrary, to the extent that the amount paid under the first sentence of this Section&nbsp;7.B.(i)(a)&nbsp;exceeds the lesser
of two times (I)&nbsp;the limit of compensation set forth in section 401(a)(17) of the Code as in effect for the year in which the Termination
Date occurs, or (II)&nbsp;Executive&rsquo;s annualized compensation based upon the annual rate of pay for services to the Company for
the calendar year prior to the calendar year in which the Termination Date occurs (adjusted for any increase during that year that was
expected to continue indefinitely if Executive had not separated from service), then the Company shall make an additional separate lump
sum payment to Executive equal to the excess amount. Such lump sum payment shall be a separate payment from the installment payments provided
under this Section&nbsp;7.B.(i)(a)&nbsp;and shall be paid to Executive on the Company&rsquo;s first payroll date following the 60th day
after the Termination Date but in no event later than two and one-half (2 &frac12;) months after the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Cash
Bonus Payment.</B></FONT> The Company shall pay to Executive an amount equal to two (2)&nbsp;times Executive&rsquo;s target annual cash
incentive bonus for the calendar year in which the Termination Date occurs, less deductions and withholding required by law, payable in
a lump sum at the same time as other eligible employees under the Company&rsquo;s annual cash incentive bonus plan for such calendar year
are paid their bonuses under such Company&rsquo;s annual cash incentive bonus plan for such calendar year, but in any event no later than
March&nbsp;15 of the calendar year immediately following the calendar year in which the Termination Date occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Benefits
Continuation.</B></FONT> If Executive was enrolled in a group health plan (<I>e.g.</I>, medical, dental, or vision plan) sponsored by
the Company immediately prior to the Termination Date, and if Executive (or Executive&rsquo;s eligible dependents) timely elects to continue
such coverage under COBRA, then the Company will pay to the insurance carrier(s)&nbsp;its share of the premiums due for Executive and
Executive&rsquo;s eligible dependents for the first eighteen (18) months of such coverage under COBRA (or until such earlier time as Executive
and/or Executive&rsquo;s eligible dependents are no longer eligible for COBRA coverage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Full
Accelerated Vesting of Equity.</B></FONT> Notwithstanding any language in any Equity Award or in the Plan to the contrary, if Executive
has any unvested awards of restricted stock units, options or other equity-based awards with respect to the Company as of the Termination
Date, then any such unvested awards will vest immediately as of the Termination Date. In the case of performance-based awards, the number
of Shares subject to such accelerated vesting shall be based on a determination by the Board of the degree to which any performance-based
vesting conditions will be deemed satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&#8239;&#8239;&#8239;&#8239;&#8239;Other
Termination During the Transition Period.</B></FONT>&nbsp;If the Termination Date occurs during the Transition Period for any of the following
reasons: (a)&nbsp;Executive&rsquo;s abandonment of or resignation from employment for any reason other than Good Reason; (b)&nbsp;termination
of Executive&rsquo;s employment by the Company for Cause; or (c)&nbsp;due to Executive&rsquo;s death or Disability, then the Company shall
pay to Executive, or Executive&rsquo;s beneficiary or estate, as the case may be, such base salary, bonus and benefits (including Annual
Bonus) that have been earned but not paid to Executive as of the Termination Date, payable pursuant to the Company&rsquo;s normal payroll
practices and procedures and to the extent and in the manner provided in any applicable plans or programs, pay any additional amount that
may be payable under Section&nbsp;6.B. or Section&nbsp;6.C. (as applicable) and honor Executive&rsquo;s rights under any Equity Awards,
and Executive shall not be entitled to any additional compensation or benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Additional
Payments Upon or Following a Change in Control. </B></FONT>If the Termination Date occurs during the Term and within ninety (90) days
prior to a Change in Control, and if such termination is a Qualifying Termination and Executive reasonably demonstrates within thirty
(30) days after the Change in Control that such Qualifying Termination arose in connection with or in anticipation of the Change in Control,
then the Company shall provide to Executive the following severance payments and benefits (in addition to the severance payments and benefits
Executive is eligible to receive under Section&nbsp;7.A.), each of which shall be considered a separate payment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Additional
Cash Severance. </B></FONT>The Company shall pay to Executive an amount equal to one (1)&nbsp;times Executive&rsquo;s annualized Base
Salary as of the Termination Date (or, if Executive&rsquo;s resignation was for Good Reason because the Company materially reduced Executive&rsquo;s
Base Salary, one (1)&nbsp;times Executive&rsquo;s annualized Base Salary as of immediately before such material reduction), less deductions
and withholding required by law, payable in a lump sum on the Company&rsquo;s first payroll date following the 60th day after the Termination
Date but in no event later than 75 days after the Termination Date. Such lump sum payment shall be a separate payment from any payments
under Section&nbsp;7.A.(i)(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Cash
Bonus Payment.</B></FONT> The Company shall pay to Executive an amount equal to one (1)&nbsp;times Executive&rsquo;s target annual cash
incentive bonus for the calendar year in which the Termination Date occurred, less deductions and withholding required by law, payable
as follows: (a)&nbsp;if the Change in Control and the Termination Date occur in the same calendar year, then in a lump sum at the same
time as other eligible employees under the Company&rsquo;s annual cash incentive bonus plan for such calendar year are paid their bonuses
under such Company&rsquo;s annual cash incentive bonus plan for such calendar year, but in any event no later than March&nbsp;15 of the
calendar year immediately following the calendar year in which the Termination Date occurred, or (b)&nbsp;if the Change in Control occurs
in the calendar year following the year in which the Termination Date occurred, then in a lump sum not later than 60 days after the Change
in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Benefits
Continuation Extension.</B></FONT> If Executive was enrolled in a group health plan (<I>e.g.</I>, medical, dental, or vision plan) sponsored
by the Company immediately prior to the Termination Date, and if Executive (or Executive&rsquo;s eligible dependents) timely elects to
continue such coverage under COBRA, then the Company will pay to the insurance carrier(s)&nbsp;its share of the premiums due for Executive
and Executive&rsquo;s eligible dependents for six (6)&nbsp;months of such coverage under COBRA after the initial 12-month COBRA coverage
period under Section&nbsp;7.A.(i)(c)&nbsp;ends (or until such earlier time as Executive and/or Executive&rsquo;s eligible dependents are
no longer eligible for COBRA coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Vesting
of Equity Awards.</B></FONT> The Company shall pay to Executive an amount equal to the intrinsic value of any unvested restricted stock
units, options or other equity-based awards held by Executive as of the Termination Date that were forfeited as of the Termination Date,
with such intrinsic value to be determined based on the per share price paid by the buyer for the Company&rsquo;s common stock in connection
with the Change in Control, or, if no per share price is paid by a buyer in connection with such Change in Control, the per share value
of the Company&rsquo;s common stock at the time of such Change in Control as determined in good faith by the Board as it exists prior
to the consummation of the Change in Control, in each case, less any exercise price or other amount that would have been owed to the Company
by Executive in order to realize the value of such awards. In the case of forfeited performance-based awards, the intrinsic value shall
be based on the number of Shares subject to an award based on a determination by the Board of the degree to which any performance-based
vesting or payment conditions will be deemed satisfied. Any amount payable under this Section&nbsp;7.C.(iv)&nbsp;will be subject to deductions
and withholding required by law and payable in a lump sum within the 30-day period immediately following the Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Change
in Control.</B> For purposes of this Agreement, &ldquo;<B><I>Change in Control</I></B>&rdquo; has the meaning ascribed to such term in
the Plan (as such document may be amended from time to time); provided that no Change in Control shall be deemed to have occurred unless
the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of
the assets of, the Company under Code Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Section&nbsp;409A;
Conditional Six-Month Delay.</B></FONT> Any payments under this Section&nbsp;7 (the &ldquo;<B><I>Payments</I></B>&rdquo;) are intended
to be exempt from or satisfy the requirements for deferred compensation under Section&nbsp;409A, including current and future guidance
and regulations interpreting Section&nbsp;409A, and should be interpreted and administered accordingly. However, if the Company (or, if
applicable, the successor entity thereto) determines that the Payments (or any portion of the Payments) constitute &ldquo;deferred compensation&rdquo;
under Section&nbsp;409A and Executive is a &ldquo;specified employee&rdquo; of the Company or any successor entity thereto, as such term
is defined in Section&nbsp;409A(a)(2)(B)(i)&nbsp;(a &ldquo;<B><I>Specified Employee</I></B>&rdquo;), then, solely to the extent necessary
to avoid the incurrence of the adverse personal tax consequences under Section&nbsp;409A, the timing of the Payments shall be delayed
as follows: on the earliest to occur of (i)&nbsp;the date that is six months and one day after the Termination Date, (ii)&nbsp;the date
of the Specified Employee&rsquo;s death, or (iii)&nbsp;such earlier date, as reasonably determined in good faith by the Company (or any
successor entity thereto), as would not result in any of the Payments being subject to adverse personal tax consequences under Section&nbsp;409A
(such earliest date, the &ldquo;<B><I>Delayed Initial Payment Date</I></B>&rdquo;), the Company (or the successor entity thereto, as applicable)
shall (A)&nbsp;pay to Executive a lump sum amount equal to the sum of the Payments that Executive would otherwise have received through
the Delayed Initial Payment Date if the commencement of the payment of the Payments had not been delayed pursuant to this Section&nbsp;7.E.
and (B)&nbsp;commence paying the balance of the Payments in accordance with the applicable payment schedules set forth in this Section&nbsp;7.
For the avoidance of doubt, it is intended that (1)&nbsp;each installment of the Payments is a separate &ldquo;payment&rdquo; for purposes
of Section&nbsp;409A, (2)&nbsp;all Payments satisfy, to the greatest extent possible, the exemptions from the application of Section&nbsp;409A
provided under of Treasury Regulation 1.409A-1(b)(4)-(6), and 1.409A-1(b)(9)(iii), and (3)&nbsp;the Payments consisting of COBRA premiums
also satisfy, to the greatest extent possible, the exemptions from the application of Section&nbsp;409A provided under Treasury Regulation
1.409A-1(b)(9)(v).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;280G
Limitations.</B></FONT> In the event that the severance pay and other benefits provided for in this Agreement or otherwise payable to
Executive (i)&nbsp;constitute &ldquo;parachute payments&rdquo; within the meaning of Section&nbsp;280G of the Code and (ii)&nbsp;would
be subject to the excise tax imposed by Code Section&nbsp;4999, then such benefits shall be either be: (A)&nbsp;delivered in full, or
(B)&nbsp;delivered as to such lesser extent which would result in no portion of such severance pay and other benefits being subject to
excise tax under Code Section&nbsp;4999, whichever of the foregoing amounts, taking into account the applicable federal, state and local
income and employment taxes and the excise tax imposed by Code Section&nbsp;4999, results in the receipt by Executive, on an after-tax
basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be subject to excise tax under
Code Section&nbsp;4999. Any determination required under this Section&nbsp;5.F. will be made in writing by an accounting firm selected
by the Company or such other person or entity to which the parties mutually agree (the &ldquo;<B><I>Accountants</I></B>&rdquo;), whose
determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations
required by this Section&nbsp;7.F., the Accountants may make reasonable assumptions and approximations concerning applicable taxes and
may rely on reasonable, good faith interpretations concerning the application of Code Sections 280G and 4999. The Company and Executive
shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination
under this Section&nbsp;7.F. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations
contemplated by this Section&nbsp;7.F. Any reduction in payments and/or benefits required by this Section&nbsp;7.F. shall occur in the
following order: (i)&nbsp;cash payments shall be reduced first and in reverse chronological order such that the cash payment owed on the
latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced; (ii)&nbsp;accelerated
vesting of restricted stock units, options or other equity-based awards, if any, shall be cancelled/reduced next and in the reverse order
of the date of grant for such restricted stock units, options or other equity-based awards (i.e., the vesting of the most recently granted
stock awards will be reduced first), with full-value awards reversed before any restricted stock units, options or other equity-based
awards are reduced; and (iii)&nbsp;deferred compensation amounts subject to Section&nbsp;409A shall be reduced last.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Remedies.
</B>Each of the parties to this Agreement will be entitled to enforce its rights under this Agreement specifically, to recover damages
by reason of any breach of any provision of this Agreement and to exercise all other rights existing in its favor. The parties hereto
agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this Agreement and that any
party may in its sole discretion apply to any court of law or equity of competent jurisdiction in accordance with Section&nbsp;14 for
injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Attorney
Fees. </B>If any action at law or in equity, including any action for declaratory or injunctive relief, is brought which arises out of
this Agreement or the termination of Executive&rsquo;s employment, or which seeks to enforce or interpret this Agreement or to seek damages
for its breach, the prevailing party shall be entitled to recover reasonable attorney fees from the non-prevailing party, which fees may
be set by the court or arbitrator in the trial of such action, or may be enforced in a separate action brought for that purpose, and which
fees shall be in addition to any other relief which may be awarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Assignment.
</B>This Agreement shall not be assignable, in whole or in part, by either party without the written consent of the other party, except
that the Company may, without the consent of Executive, assign or delegate all or any portion of its rights and obligations under this
Agreement to any corporation or other business entity (i)&nbsp;with which the Company may merge or consolidate, or (ii)&nbsp;to which
the Company may sell or transfer all or substantially all of its assets or capital stock. Any such current or future successor to which
any right or obligation has been assigned or delegated shall be deemed to be the &ldquo;Company&rdquo; for purposes of such rights or
obligations of this Agreement. The rights and, obligations under this Agreement shall inure to the benefit of and shall be binding upon
the heirs, legatees, administrators and personal representatives of Executive and upon the successors, affiliates, representatives and
assigns of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Severability
and Reformation. </B>The parties hereto intend all provisions of this Agreement to be enforced to the fullest extent permitted by law,
and are intended to be limited to the extent necessary so that they will not render this Agreement illegal, invalid, or unenforceable
under present or future law. If any provision of this Agreement or any application thereof shall be held to be invalid, illegal or unenforceable,
the validity, legality and enforceability of such provision shall be fully severable, and this Agreement shall be construed and enforced
as if such illegal, invalid, or unenforceable provision were never a part hereof and the remaining provisions shall remain in full force
and effect and shall not be affected by the illegal, invalid, or unenforceable provision or by its severance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Notices.
</B>All notices and other communications required or permitted to be given hereunder shall be in writing and shall be deemed to have been
duly given if delivered personally, mailed by certified mail (return receipt requested) or sent by overnight delivery service, cable,
telegram, facsimile transmission or telex to the parties at the following addresses or at such other addresses as shall be specified by
the parties by like notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Proto Labs,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5540 Pioneer Creek Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Maple Plain, MN 55359</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Attention: Board Chair</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The last known address on file with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notice so given shall, in
the case of notice so given by mail, be deemed to be given and received on the fourth calendar day after posting, in the case of notice
so given by overnight delivery service, on the date of actual delivery and, in the case of notice so given by cable, telegram, facsimile
transmission, telex or personal delivery, on the date of actual transmission or, as the case may be, personal delivery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Further
Actions. </B>Whether or not specifically required under the terms of this Agreement, each party hereto shall execute and deliver such
documents and take such further actions as shall be necessary in order for such party to perform all of the party&rsquo;s obligations
specified herein or reasonably implied from the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Taxes.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>The
Company may withhold from any amounts payable under this Agreement such federal, state and local income and employment taxes as the Company
determines are required or authorized to be withheld pursuant to any applicable law or regulation. Except for any tax amounts withheld
by the Company from any compensation that Executive may receive in connection with Executive&rsquo;s employment with the Company and any
employer taxes required to be paid by the Company under applicable laws or regulations, Executive is solely responsible for payment of
any and all taxes owed in connection with any compensation, benefits, reimbursement amounts or other payments Executive receives from
the Company under this Agreement or otherwise in connection with Executive&rsquo;s employment with the Company. The Company does not guarantee
any particular tax consequence or result with respect to any payment made by the Company. In no event should this Section&nbsp;14 or any
other provision of this Agreement be construed to require the Company to provide any gross-up for the tax consequences of any provisions
of, or payments under, this Agreement, and the Company has no responsibility for tax or legal consequences to Executive resulting from
the terms or operation of this Agreement; provided, however, to the extent that any post-termination COBRA premiums paid by the Company
under Section&nbsp;7 of this Agreement shall be taxable at the Termination Date or during the period for which such COBRA premiums are
provided, then the Company shall pay to Executive an additional amount for each such month that the COBRA premiums are taxable.&nbsp;
The monthly amount will equal 15% of the applicable COBRA premium for that month and such amount will be paid to Executive within two
and one half months after the month to which they relate, provided that the aggregate amount payable to Executive under this provision
will not exceed the dollar limit in effect under Code section 402(g)(1)(B)&nbsp;for the year of the Termination Date, as provided in Treasury
Regulations section 1.409A-1(b)(9)(v)(D).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Indemnification</B>.
At all times while Executive is employed by the Company, and at all times following the Termination Date with respect to matters relating
to Executive&rsquo;s employment with the Company, the Company shall continue to provide to Executive indemnification, director&rsquo;s
and officer&rsquo;s liability insurance and other protection from personal liability with respect to Executive&rsquo;s employment with
the Company in accordance with applicable law, the Company&rsquo;s by-laws and governance documents, and applicable insurance policies
as may be in place from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Governing
Law and Venue. </B>This Agreement is to be governed by and construed in accordance with the laws of the State of Minnesota without giving
effect to any choice or conflict of law provision or rule&nbsp;that would cause the application of laws of any jurisdiction other than
the State of Minnesota. The parties agree that any dispute concerning this Agreement is to be brought in the District Court in Hennepin
County, Minnesota and consent to jurisdiction and venue therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Entire
Agreement. </B>This Agreement, the Restrictive Covenants Agreement, the Award Agreements and the Plan contain the entire understanding
and agreement between the parties, except as otherwise specified herein, and supersede any other agreement between Executive and the Company,
whether oral or in writing, with respect to the same subject matter; <I>provided, however</I>, that nothing herein shall supersede or
replace any of the Company&rsquo;s equity-based compensation plans and any award agreements with the Executive entered into thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>No
Waiver. </B>No term or condition of this Agreement shall be deemed to have been waived, except by a statement in writing signed by the
party against whom enforcement of the waiver is sought. Any written waiver shall not be deemed a continuing waiver unless specifically
stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for
the future or as to any act other than that specifically waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Counterparts.
</B>This Agreement may be executed in counterparts, with the same effect as if both parties had signed the same document. All such counterparts
shall be deemed an original, shall be construed together and shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[signature page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>In
Witness Whereof</B></FONT>, the parties have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THE COMPANY:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps"><B>Proto Labs,&nbsp;Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">/s/ Rainer Gawlick</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Rainer Gawlick</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXECUTIVE:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%">/s/ Suresh Krishna</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Suresh Krishna</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Executive Employment Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>tm2515767d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Proto Labs,&nbsp;Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>5540 Pioneer Creek Drive</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Maple Plain, MN 55359</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May&nbsp;20, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert Bodor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To his last known address</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">on file with Proto Labs</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Rob:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are pleased to extend an offer of a short-term
consulting arrangement between Proto Labs,&nbsp;Inc. (&ldquo;<U>Proto Labs</U>&rdquo;) and you (&ldquo;<U>Consultant</U>&rdquo; or &ldquo;<U>you</U>&rdquo;)
for the period from today through May&nbsp;25, 2025 (the &ldquo;<U>Term</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are the terms of this Consulting
Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the Term, Consultant
shall provide such services as the Board of the Directors of Proto Labs reasonably determines are necessary to support the transition
of management of Proto Labs (the &ldquo;<U>Services</U>&rdquo;). Consultant may determine, in his sole discretion, the means and manner
of performing the Services. </FONT>Proto Labs retains the right to require that Consultant satisfactorily perform the Services. Consultant
may perform the Services from the location(s)&nbsp;selected by Consultant. Consultant agrees to perform the Services in accordance with
generally accepted standards of Consultant&rsquo;s profession.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In exchange for the Services,
</FONT>Proto Labs will pay Consultant an hourly fee of $700.00 per hour (collectively, the &ldquo;<U>Hourly Fees</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as otherwise approved
in advance by </FONT>Proto Labs, expenses and costs incurred by Consultant in the performance of the Services shall be paid and borne
solely by Consultant without reimbursement from Proto Labs.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes:</FONT></TD><TD STYLE="text-align: justify">Proto Labs will neither withhold FICA or income tax payments nor withhold any amounts for, or make any
contributions on account of, unemployment compensation, worker&rsquo;s compensation, employee benefit plans or otherwise pursuant to any
United States, state, or local law or regulation with respect to the compensation it pays Consultant. Consultant acknowledges and agrees
that Consultant shall have sole responsibility for withholding and payment of all United States, state and local taxes or contributions
imposed or required under unemployment insurance, social security and income tax laws and for filing all required tax forms with respect
to any amounts paid by Proto Labs to Consultant hereunder, and agrees that Consultant shall pay all such taxes and contributions in accordance
with applicable law (including making such payments when due).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relationship:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant&rsquo;s relationship
to </FONT>Proto Labs shall be that of an independent contractor and not as an employee of Proto Labs. The parties do not intend that any
agency or partnership relationship be created between them by this Consulting Agreement. Consultant understands and agrees that Consultant
is not an employee of Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 1.1in">Governing Law &amp; Venue:</TD>
  <TD STYLE="text-align: justify">The validity, interpretation and performance of this Consulting Agreement shall be governed by the laws of the State of Minnesota, excluding
its conflict of law principles. All litigation or other legal proceedings arising out of or related to this Consulting Agreement shall
only be brought in the state courts of the State of Minnesota and the United States District Court located therein, and the parties hereby
submit to the exclusive personal and subject matter jurisdiction and venue of such courts and waive and defense based on lack of jurisdiction
or inconvenient forum. The award, order and/or judgment of any such court may be entered in any court of competent jurisdiction.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
accept this Consulting Agreement, Consultant must counter-sign below and return the signed Consulting Agreement to me no later than 5:00
p.m.&nbsp;Central Standard Time on May&nbsp;20, 2025. This Consulting Agreement sets forth the entire agreement and understanding between
Proto Labs and Consultant regarding the subject matter of this Consulting Agreement and supersedes any and all other agreements, either
oral or in writing, between </FONT>Proto Labs and Consultant related to such subject matter. For avoidance of doubt, this Consulting Agreement
does not supersede or modify the terms of the Employment Agreement, the Non-Disclosure Agreement, or Non-Competition Agreement (each as
defined in the General Waiver and Release of Claims provided to Consultant on May&nbsp;20, 2025) that survive Consultant&rsquo;s last
day of employment with Proto Labs, which shall remain in full force and effect in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> Sincerely,</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Proto
Labs, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Rainer Gawlick</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">Name: Rainer Gawlick</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">Its: Chairman of the Board of Directors</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I have read and accepted the terms of this Consulting Agreement as
of this 20<SUP>th</SUP> day of May, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Robert Bodor</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Robert Bodor</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>tm2515767d1_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROTO LABS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2022 LONG-TERM INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(As Amended May&nbsp;20, 2025)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Purpose</U>. The purpose of the Proto
Labs,&nbsp;Inc. 2022 Long-Term Incentive Plan, as amended and restated (the &ldquo;Plan&rdquo;) is to help attract and retain the best
available people for positions of responsibility with the Company, to provide additional incentives to them and align their interests
with those of the Company&rsquo;s shareholders, and to thereby promote the Company&rsquo;s long-term business success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Original Plan; Effective Dates</U>.
The Plan became effective on August&nbsp;29, 2022 (the &ldquo;Effective Date&rdquo;), and was amended and restated effective May&nbsp;17,
2023. The Board has adopted this Amended and Restated Plan on February&nbsp;13, 2024, subject to approval by the Company&rsquo;s shareholders,
which date of shareholder approval is referred to as the &ldquo;Amended and Restated Effective Date&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt"><B>2.&#8239;&#8239;&emsp;<U>Definitions</U>.</B></FONT>
In this Plan, the following definitions will apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;&ldquo;Affiliate&rdquo; means any entity
that is a Subsidiary or Parent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;&ldquo;Agreement&rdquo; means the written
or electronic agreement containing the terms and conditions applicable to an Award granted under the Plan. An Agreement is subject to
the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;&ldquo;Award&rdquo; means the grant of
a compensatory award under the Plan in the form of an Option, Stock Appreciation Rights, Restricted Stock, Stock Units, Other Stock-Based
Award or Cash Incentive Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;&ldquo;Board&rdquo; means the Board of
Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&emsp;&ldquo;Cash Incentive Award&rdquo; means
an Award described in Section&nbsp;11 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&emsp;&ldquo;Cause&rdquo; means what the term
is expressly defined to mean in a then-effective written agreement (including an Agreement) between a Participant and the Company or any
Affiliate or, in the absence of any such then-effective agreement or definition, means a Participant&rsquo;s (i)&nbsp;failure or refusal
to perform satisfactorily the duties reasonably required of the Participant by the Company (other than by reason of Disability); (ii)&nbsp;material
violation of any law, rule, regulation, court order or regulatory directive (other than traffic violations, misdemeanors or other minor
offenses); (iii)&nbsp;material breach of any Company code of conduct or Company policy, of any agreement with the Company or any Affiliate,
or of any nondisclosure, non-solicitation, non-competition or similar obligation owed to the Company or any Affiliate; (iv)&nbsp;engaging
in any act or practice that involves personal dishonesty on the part of the Participant or demonstrates a willful and continuing disregard
for the best interests of the Company and its Affiliates; or (v)&nbsp;engaging in conduct that would be reasonably expected to harm or
bring disrepute to the Company, any of its Affiliates, or any of their customers, employees or vendors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(g)&emsp;&ldquo;Change in Control&rdquo; means
one of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;An Exchange Act Person becomes the beneficial
owner (within the meaning of Rule&nbsp;13d-3 under the Exchange Act) of securities of the Company representing more than 50% of the combined
voting power of the Company&rsquo;s then outstanding Voting Securities, except that the following will not constitute a Change in Control:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(A) &#8239;&#8239;any acquisition of securities of the
Company by an Exchange Act Person directly or indirectly from the Company for the purpose of providing financing to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(B)&#8239;&#8239;&#8239;&#8239;any formation of a Group consisting solely
of beneficial owners of the Company&rsquo;s Voting Securities as of the Effective Date of this Plan; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(C)&#8239;&#8239;&#8239;&#8239;any Exchange Act Person becomes the beneficial
owner of more than 50% of the combined voting power of the Company&rsquo;s outstanding Voting Securities as the result of any repurchase
or other acquisition by the Company of its Voting Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If, however, an Exchange Act Person or Group referenced
in clause (A), (B)&nbsp;or (C)&nbsp;above acquires beneficial ownership of additional Company Voting Securities after initially becoming
the beneficial owner of more than 50% of the combined voting power of the Company&rsquo;s outstanding Voting Securities by one of the
means described in those clauses, then a Change in Control shall be deemed to have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;Individuals who are Continuing Directors
cease for any reason to constitute a majority of the members of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&emsp;The consummation of a Corporate Transaction
unless, immediately following such Corporate Transaction, all or substantially all of the individuals and entities who were the beneficial
owners of the outstanding Company Voting Securities immediately prior to such Corporate Transaction beneficially own, directly or indirectly,
more than 50% of the combined voting power of the then outstanding Voting Securities of the of the surviving or acquiring entity (or its
Parent) resulting from such Corporate Transaction in substantially the same proportions as their ownership, immediately before such Corporate
Transaction, of the outstanding Company Voting Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notwithstanding the foregoing, no Change in Control
shall be deemed to have occurred upon an event described in Section&nbsp;2(g)&nbsp;unless the event would also constitute a change in
ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under Code Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(h)&emsp;&ldquo;Code&rdquo; means the Internal
Revenue Code of 1986, as amended and in effect from time to time. For purposes of the Plan, references to sections of the Code shall be
deemed to include any applicable regulations and guidance promulgated thereunder and any successor or similar statutory provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(i)&#8239;&emsp;&ldquo;Code Section&nbsp;409A&rdquo;
means Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(j)&#8239;&emsp;&ldquo;Committee&rdquo; means two or
more Non-Employee Directors designated by the Board to administer the Plan under Section&nbsp;3, each member of which shall (i)&nbsp;satisfy
the independence requirements for independent directors and members of compensation committees as set forth from time to time in the Listing
Rules&nbsp;of the Nasdaq Stock Market and (ii)&nbsp;be a non-employee director within the meaning of Exchange Act Rule&nbsp;16b-3. The
Committee shall be the Compensation and Talent Committee of the Board unless otherwise specified by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(k)&emsp;&ldquo;Company&rdquo; means Proto Labs,&nbsp;Inc.,
a Minnesota corporation, or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(l)&#8239;&emsp;&ldquo;Continuing Director&rdquo; means
an individual (A)&nbsp;who is, as of the Effective Date of the Plan, a director of the Company, or (B)&nbsp;who becomes a director of
the Company subsequent to the Effective Date of the Plan and whose initial election, or nomination for initial election by the Company&rsquo;s
shareholders, was approved by at least a majority of the then Continuing Directors, but excluding, for purposes of this clause (B), any
such individual whose initial assumption of office occurs as a result of an actual or threatened proxy contest involving the solicitation
of proxies or consents by a person or Group other than the Board, or by reason of an agreement intended to avoid or settle an actual or
threatened proxy contest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(m)&#8239;&#8239;&#8239;&ldquo;Corporate Transaction&rdquo; means
a reorganization, merger, consolidation or statutory share exchange involving the Company, regardless of whether the Company is the surviving
entity, or a sale or other disposition (in one or a series of transactions) of all or substantially all of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(n)&emsp;&ldquo;Disability&rdquo; means &ldquo;total
and permanent disability&rdquo; within the meaning of Code Section&nbsp;22(e)(3).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(o)&emsp;&ldquo;Employee&rdquo; means an employee
of the Company or an Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(p)&emsp;&ldquo;Exchange Act&rdquo; means the
Securities Exchange Act of 1934, as amended and in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(q)&emsp;&ldquo;Exchange Act Person&rdquo; means
any natural person, entity or Group other than (i)&nbsp;the Company or any Subsidiary of the Company; (ii)&nbsp;any employee benefit plan
(or related trust) sponsored or maintained by the Company or any Affiliate; (iii)&nbsp;an underwriter temporarily holding securities in
connection with a registered public offering of such securities; or (iv)&nbsp;an entity owned, directly or indirectly, by the shareholders
of the Company in substantially the same proportions as their ownership of stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(r)&emsp;&ldquo;Fair Market Value&rdquo; means
the closing sales price for a Share on the New York Stock Exchange as reported in <I>The Wall Street Journal </I>or such other source
as the Committee deems reliable, or if no sale of Shares occurred on that date, on the next preceding date on which a sale of Shares occurred;
provided, however, that if the Shares are not then readily tradable on an established securities market (as determined under Code Section&nbsp;409A),
or if Fair Market Value for any date cannot be so determined, then Fair Market Value will be determined by the Committee as the result
of a reasonable application of a reasonable valuation method that satisfies the requirements of Code Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(s)&emsp;&ldquo;Full Value Award&rdquo; means
an Award other than an Option Award, Stock Appreciation Rights Award or Cash Incentive Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(t)&emsp;&ldquo;Grant Date&rdquo; means the date
on which the Committee approves the grant of an Award under the Plan, or such later date as may be specified by the Committee on the date
the Committee approves the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(u)&emsp;&ldquo;Global Service Provider&rdquo;
means a Service Provider who is located outside of the United States, who is not compensated from a payroll maintained in the United States,
or who is otherwise subject to (or could cause the Company to be subject to) legal, tax or regulatory requirements of countries outside
of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(v)&emsp;&ldquo;Group&rdquo; means two or more
persons who act, or agree to act together, as a partnership, limited partnership, syndicate or other group for the purpose of acquiring,
holding, voting or disposing of securities of the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(w)&emsp;&ldquo;Non-Employee Director&rdquo; means
a member of the Board who is not an Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(x)&emsp;&ldquo;Option&rdquo; means a right granted
under the Plan to purchase a specified number of Shares at a specified price during a specified period of time. An &ldquo;Incentive Stock
Option&rdquo; or &ldquo;ISO&rdquo; means any Option designated as such and granted in accordance with the requirements of Code Section&nbsp;422.
A &ldquo;Non-Statutory Stock Option&rdquo; means an Option other than an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(y)&emsp;&ldquo;Other Stock-Based Award&rdquo;
means an Award described in Section&nbsp;11 of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(z)&emsp;&ldquo;Parent&rdquo; means a &ldquo;parent
corporation,&rdquo; as defined in Code Section&nbsp;424(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(aa)&#8239;&#8239;&ldquo;Participant&rdquo; means a Service
Provider to whom an Award is or has been made in accordance with the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(bb)&#8239;&#8239;&ldquo;Performance-Based Award&rdquo;
means an Award that is conditioned on the achievement of specified performance goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(cc)&#8239;&#8239;&ldquo;Plan&rdquo; means this Proto
Labs,&nbsp;Inc. 2022 Long-Term Incentive Plan, as amended and in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(dd)&#8239;&#8239;&ldquo;Prior Plan&rdquo; means the Proto
Labs,&nbsp;Inc. 2012 Long-Term Incentive Plan, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(ee)&#8239;&#8239;&ldquo;Restricted Stock&rdquo; means
Shares issued to a Participant that are subject to such restrictions on transfer, vesting conditions and other restrictions or limitations
as may be set forth in this Plan and the applicable Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(ff)&#8239;&#8239;&#8239;&#8239;&ldquo;Service&rdquo; means the provision
of services by a Participant to the Company or any Affiliate in any Service Provider capacity. A Service Provider&rsquo;s Service shall
be deemed to have terminated either upon an actual cessation of providing services to the Company or any Affiliate or upon the entity
for which the Service Provider provides services ceasing to be an Affiliate. Except as otherwise provided in this Plan or any Agreement,
Service shall not be deemed terminated in the case of (i)&nbsp;any approved leave of absence; (ii)&nbsp;transfers among the Company and
any Affiliates in any Service Provider capacity; or (iii)&nbsp;any change in status so long as the individual remains in the service of
the Company or any Affiliate in any Service Provider capacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(gg)&#8239;&#8239;&ldquo;Service Provider&rdquo; means
an Employee, a Non-Employee Director, or any consultant or advisor, who is a natural person and who provides services (other than in connection
with (i)&nbsp;a capital-raising transaction or (ii)&nbsp;promoting or maintaining a market in Company securities) to the Company or any
Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(hh)&#8239;&#8239;&ldquo;Share&rdquo; means a share of
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(ii)&emsp;&ldquo;Stock&rdquo; means the common
stock, par value $0.001 per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(jj)&emsp;&ldquo;Stock Appreciation Right&rdquo;
or &ldquo;SAR&rdquo; means a right granted under the Plan to receive, in cash and/or Shares as determined by the Committee, an amount
equal to the appreciation in value of a specified number of Shares between the Grant Date of the SAR and its exercise date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(kk)&#8239;&#8239;&ldquo;Stock Unit&rdquo; means a right
granted under the Plan to receive, in cash and/or Shares as determined by the Committee, the Fair Market Value of a Share, subject to
such restrictions on transfer, vesting conditions and other restrictions or limitations as may be set forth in this Plan and the applicable
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(ll)&emsp;&ldquo;Subsidiary&rdquo; means a &ldquo;subsidiary
corporation,&rdquo; as defined in Code Section&nbsp;424(f), of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(mm)&#8239;&ldquo;Substitute Award&rdquo; means
an Award granted upon the assumption of, or in substitution or exchange for, outstanding awards granted by a company or other entity acquired
by the Company or any Affiliate or with which the Company or any Affiliate combines. The terms and conditions of a Substitute Award may
vary from the terms and conditions set forth in the Plan to the extent that the Committee at the time of the grant may deem appropriate
to conform, in whole or in part, to the provisions of the award in substitution for which it has been granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(nn)&#8239;&#8239;&ldquo;Voting Securities&rdquo; of an
entity means the outstanding securities entitled to vote generally in the election of directors (or comparable equity interests) of such
entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>3.&#8239;&emsp;<U>Administration of the Plan</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Administration</U>. The authority
to control and manage the operations and administration of the Plan shall be vested in the Committee in accordance with this Section&nbsp;3.
Notwithstanding the foregoing sentence, the Board shall perform the duties and have the responsibilities of the Committee with respect
to Awards made to Non-Employee Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Scope of Authority</U>. Subject to
the terms of the Plan, the Committee shall have the authority, in its discretion, to take such actions as it deems necessary or advisable
to administer the Plan, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;determining the Service Providers to
whom Awards will be granted, the timing of each such Award, the types of Awards and the number of Shares or amount of cash covered by
each Award, the terms, conditions, performance criteria, restrictions and other provisions of Awards, and the manner in which Awards are
paid or settled;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;cancelling or suspending an Award or
the exercisability of an Award, accelerating the vesting or extending the exercise period of an Award, or otherwise amending the terms
and conditions of any outstanding Award, subject to the requirements of Sections 6(b), 15(d)&nbsp;and 15(e);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&emsp;establishing, amending or rescinding
rules&nbsp;to administer the Plan, interpreting the Plan and any Award or Agreement made under the Plan, and making all other determinations
necessary or desirable for the administration of the Plan; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(4)&emsp;taking such actions as are described
in Section&nbsp;3(c)&nbsp;with respect to Awards to Global Service Providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;<U>Awards to Global Service Providers</U>.
The Committee may grant Awards to Global Service Providers, on such terms and conditions different from those specified in the Plan as
may, in the judgment of the Committee, be necessary or desirable to comply with applicable foreign laws and regulatory requirements and
to promote achievement of the purposes of the Plan. In connection therewith, the Committee may establish such subplans or annexes to Award
Agreements and may modify exercise procedures and other Plan rules&nbsp;and procedures to the extent such actions are deemed necessary
or desirable, and may take any other action that it deems advisable to obtain local regulatory approvals or to comply with any necessary
local governmental regulatory exemptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;<U>Acts of the Committee; Delegation</U>.
A majority of the members of the Committee shall constitute a quorum for any meeting of the Committee, and any act of a majority of the
members present at any meeting at which a quorum is present or any act unanimously approved in writing by all members of the Committee
shall be the act of the Committee. Any such action of the Committee shall be valid and effective even one or more of the members of the
Committee at the time of such action are later determined not to have satisfied all of the criteria for membership in clauses (i)&nbsp;or
(ii)&nbsp;of Section&nbsp;2(j). To the extent not inconsistent with applicable law or stock exchange rules, the Committee may delegate
all or any portion of its authority under the Plan to any one or more of its members or, as to Awards to Participants who are not subject
to Section&nbsp;16 of the Exchange Act, to one or more directors or executive officers of the Company, or to a committee of the Board
comprised of one or more directors of the Company. The Committee may also delegate non-discretionary administrative responsibilities in
connection with the Plan to such other persons as it deems advisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&emsp;<U>Finality of Decisions</U>. The Committee&rsquo;s
interpretation of the Plan and of any Award or Agreement made under the Plan and all related decisions or resolutions of the Board or
Committee shall be final and binding on all parties with an interest therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&emsp;<U>Indemnification</U>. Each person who
is or has been a member of the Committee or of the Board, and any other person to whom the Committee delegates authority under the Plan,
shall be indemnified by the Company, to the maximum extent permitted by law, against liabilities and expenses imposed upon or reasonably
incurred by such person in connection with or resulting from any claims against such person by reason of the performance of the individual&rsquo;s
duties under the Plan. This right to indemnification is conditioned upon such person providing the Company an opportunity, at the Company&rsquo;s
expense, to handle and defend the claims before such person undertakes to handle and defend them on such person&rsquo;s own behalf. The
Company will not be required to indemnify any person for any amount paid in settlement of a claim unless the Company has first consented
in writing to the settlement. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to
which such person or persons may be entitled under the Company&rsquo;s Articles of Incorporation or Bylaws, as a matter of law, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>4.&emsp;<U>Shares Available Under the Plan</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Maximum Shares Available</U>. Subject
to the provisions of this Section&nbsp;4 and to adjustment as provided in Section&nbsp;12(a), the number of Shares that may be the subject
of Awards and issued under the Plan shall be (i)&nbsp;2,225,500, plus (ii)&nbsp;any Shares subject to outstanding awards under the Prior
Plan that expire, are cancelled, or are otherwise forfeited, plus (iii)&nbsp;296,000. Shares to be issued under the Plan shall be authorized
and unissued Shares. In determining the number of Shares to be counted against this share reserve in connection with any Award, the following
rules&nbsp;shall apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;Where the number of Shares subject to
an Award is variable on the Grant Date, the number of Shares to be counted against the share reserve shall be the maximum number of Shares
that could be received under that particular Award, until such time as it can be determined that only a lesser number of shares could
be received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;Where two or more types of Awards are
granted to a Participant in tandem with each other, such that the exercise of one type of Award with respect to a number of Shares cancels
at least an equal number of Shares of the other, the number of Shares to be counted against the share reserve shall be the largest number
of Shares that would be counted against the share reserve under either of the Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&emsp;Shares subject to Substitute Awards shall
not be counted against the share reserve, nor shall they reduce the Shares authorized for grant to a Participant in any calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(4)&emsp;Awards that may be settled solely in
cash shall not be counted against the share reserve, nor shall they reduce the Shares authorized for grant to a Participant in any calendar
year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Effect of Forfeitures and Other Actions</U>.
Any Shares subject to an Award, or to an award granted under the Prior Plan that is outstanding on the Effective Date of this Plan (a
 &ldquo;Prior Plan Award&rdquo;), that is cancelled, expires or forfeited or is settled for cash shall, to the extent of such cancellation,
forfeiture, expiration or cash settlement, again become available for Awards under this Plan, the share reserve under Section&nbsp;4(a)&nbsp;shall
be correspondingly replenished as provided in Section&nbsp;4(c)&nbsp;below. The following Shares shall not, however, again become available
for Awards or replenish the share reserve under Section&nbsp;4(a): (i)&nbsp;Shares tendered (either actually or by attestation) by the
Participant or withheld by the Company in payment of the exercise price of a stock option issued under this Plan or the Prior Plan, (ii)&nbsp;Shares
tendered (either actually or by attestation) by the Participant or withheld by the Company to satisfy any tax withholding obligation with
respect to an Award or Prior Plan Award, (iii)&nbsp;Shares repurchased by the Company with proceeds received from the exercise of an option
issued under this Plan or the Prior Plan, and (iv)&nbsp;Shares subject to a stock appreciation right award issued under this Plan or the
Prior Plan that are not issued in connection with the stock settlement of that Award upon its exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;<U>Counting Shares Again Available</U>.
Each Share that again becomes available for Awards as provided in Section&nbsp;4(b)&nbsp;shall correspondingly increase the share reserve
under Section&nbsp;4(a), with such increase based on the same share ratio by which the applicable share reserve was decreased upon the
grant of the applicable award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;<U>Effect of Plans Operated by Acquired
Companies</U>. If a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares
available under a pre-existing plan approved by shareholders and not adopted in contemplation of such acquisition or combination, the
shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange
ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable
to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall
supplement the share reserve under Section&nbsp;4(a). Awards using such available shares shall not be made after the date awards or grants
could have been made under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals
who were not Employees or Non-Employee Directors prior to such acquisition or combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&emsp;<U>No Fractional Shares</U>. Unless otherwise
determined by the Committee, the number of Shares subject to an Award shall always be a whole number. No fractional Shares may be issued
under the Plan, but the Committee may, in its discretion, adopt any rounding convention it deems suitable or pay cash in lieu of any fractional
Share in settlement of an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&emsp;<U>Limits on Awards to Non-Employee Directors</U>.
The aggregate grant date fair value (as determined in accordance with generally accepted accounting principles applicable in the United
States) of all Awards granted during any calendar year to any Non-Employee Director, together with the amount of any cash fees or retainers
paid to such Non-Employee Director during such calendar year with respect to such individual&rsquo;s Service as a Non-Employee Director
shall not exceed $750,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt"><B>5.&#8239;&emsp;<U>Eligibility</U>.</B></FONT>
Participation in the Plan is limited to Service Providers. Incentive Stock Options may only be granted to Employees who are not Global
Service Providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>6.&#8239;&emsp;<U>General Terms of Awards</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Award Agreement</U>. Except for any
Award that involves only the immediate issuance of unrestricted Shares, each Award shall be evidenced by an Agreement setting forth the
number of Shares subject to the Award together with such other terms and conditions applicable to the Award (and not inconsistent with
the Plan) as determined by the Committee. If an Agreement calls for acceptance by the Participant, the Award evidenced by the Agreement
will not become effective unless acceptance of the Agreement in a manner permitted by the Committee is received by the Company within
30 days of the date the Agreement is delivered to the Participant. An Award to a Participant may be made singly or in combination with
any form of Award. Two types of Awards may be made in tandem with each other such that the exercise of one type of Award with respect
to a number of Shares reduces the number of Shares subject to the related Award by at least an equal amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Vesting and Term</U>. Each Agreement
shall set forth the period until the applicable Award is scheduled to vest and, if applicable, expire (which shall not be more than ten
years from the Grant Date), and consistent with the requirements of this Section&nbsp;6, the applicable vesting conditions and any applicable
performance period. Awards that vest based solely on the satisfaction by the Participant of service-based vesting conditions shall be
subject to a vesting period of not less than one year from the applicable Grant Date (during which no portion of the award may be scheduled
to vest), and Awards whose grant or vesting is subject to the satisfaction of performance goals over a performance period shall be subject
to a performance period of not less than one year. The foregoing minimum vesting and performance periods will not, however, apply in connection
with: (i)&nbsp;a Change in Control as provided in Sections 12(b)&nbsp;or 12(c), (ii)&nbsp;a Separation from Service due to death or Disability,
(iii)&nbsp;to a Substitute Award that does not reduce the vesting period of the award being replaced, (iv)&nbsp;Awards made in payment
of or exchange for other compensation already earned and payable, and (v)&nbsp;outstanding, exercised and settled Awards involving an
aggregate number of Shares not in excess of 5% of the Plan&rsquo;s share reserve specified in Section&nbsp;4(a). For purposes of Awards
to Non-Employee Directors, a vesting period will be deemed to be one year if runs from the date of one annual meeting of the Company&rsquo;s
stockholders to the date of the next annual meeting of the Company&rsquo;s shareholders. Unless the Committee provides otherwise, the
vesting of Awards granted hereunder will continue to vest during any unpaid leave of absence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;<U>Transferability</U>. Except as provided
in this Section&nbsp;6(c), (i)&nbsp;during the lifetime of a Participant, only the Participant or the Participant&rsquo;s guardian or
legal representative may exercise an Option or SAR, or receive payment with respect to any other Award; and (ii)&nbsp;no Award may be
sold, assigned, transferred, exchanged or encumbered, voluntarily or involuntarily, other than by will or the laws of descent and distribution.
Any attempted transfer in violation of this Section&nbsp;6(c)&nbsp;shall be of no effect. The Committee may, however, provide in an Agreement
or otherwise that an Award (other than an Incentive Stock Option) may be transferred pursuant to a domestic relations order or may be
transferable by gift to any &ldquo;family member&rdquo; (as defined in General Instruction A(1)(a)(5)&nbsp;to Form&nbsp;S-8 under the
Securities Act of 1933) of the Participant. Any Award held by a transferee shall continue to be subject to the same terms and conditions
that were applicable to that Award immediately before the transfer thereof. For purposes of any provision of the Plan relating to notice
to a Participant or to acceleration or termination of an Award upon the death or termination of Service of a Participant, the references
to &ldquo;Participant&rdquo; shall mean the original grantee of an Award and not any transferee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;<U>Designation of Beneficiary</U>. The
Committee may permit each Participant to designate a beneficiary or beneficiaries to exercise any Award or receive a payment under any
Award that is exercisable or payable on or after the Participant&rsquo;s death. Any such designation shall be on a written or electronic
form approved by the Committee and shall be effective upon its receipt by the Company or an agent selected by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&emsp;<U>Termination of Service</U>. Unless
otherwise provided in an Agreement, and subject to Sections 6(i)&nbsp;and 12 of this Plan, if a Participant&rsquo;s Service with the Company
and all of its Affiliates terminates, the following provisions shall apply (in all cases subject to the originally scheduled expiration
of an Option or Stock Appreciation Right Award, as applicable):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;Upon termination of Service for Cause,
or upon conduct during a post-termination exercise period that would constitute Cause, all unexercised Options and SARs and all unvested
portions of any other outstanding Awards shall be immediately forfeited without consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;Upon termination of Service due to death
or Disability, any unvested portion of an Award shall immediately become vested (and exercisable, if applicable), and the vested and exercisable
portions of Options or SARs may be exercised for a period of twelve months after the date of such termination and shall terminate upon
the expiration of such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&emsp;Upon a termination of Service for any
reason other than Cause, death or Disability, all unvested and unexercisable portions of any outstanding Awards shall be immediately forfeited
without consideration, but the currently vested and exercisable portions of Options and SARs may be exercised for a period of three months
after the date of such termination and shall, subject to the following sentence, terminate upon the expiration of such period. However,
if a Participant dies during such three-month post-termination exercise period, then the applicable post-termination exercise period shall
be extended to twelve months after the date of such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&emsp;<U>Rights as Shareholder</U>. No Participant
shall have any rights as a shareholder with respect to any Shares covered by an Award unless and until the date the Participant becomes
the holder of record of the Shares, if any, to which the Award relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(g)&emsp;<U>Performance-Based Awards</U>. Any
Award may be granted as Performance-Based Award if the Committee establishes one or more measures of corporate, Subsidiary, business unit
or individual performance which must be attained, and the performance period over which the specified performance is to be attained, as
a condition to the grant, vesting, exercisability, lapse of restrictions and/or settlement in cash or Shares of such Award. In connection
with any such Award, the Committee shall determine the extent to which performance measures have been attained and other applicable terms
and conditions have been satisfied, and the degree to which the grant, vesting, exercisability, lapse of restrictions and/or settlement
of such Award has been earned. Any Performance-Based Award shall additionally be subject to the requirements of Section&nbsp;17 of this
Plan. Except as provided in Section&nbsp;17 with respect to Performance-Based Award, the Committee shall also have the authority to provide,
in an Agreement or otherwise, for the modification of a performance period and/or an adjustment or waiver of the achievement of performance
goals upon the occurrence of events that are unusual in nature or infrequently occurring, such as a Change of Control, a Corporate Transaction,
an equity restructuring, a recapitalization, a divestiture, a change in the accounting practices of the Company, or the Participant&rsquo;s
death or Disability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(h)&emsp;<U>Dividends and Dividend Equivalents</U>.
Any dividends, dividend equivalents or distributions paid with respect to Shares that are subject to the unvested portion of an Award
will be subject to the same restrictions as the Shares to which such dividends or distributions relate. No dividends, dividend equivalents
or distributions will be paid with respect to Shares subject to an Option or SAR Award. In its discretion, the Committee may provide in
an Agreement for a Stock Unit Award or an Other Stock-Based Award that the Participant will be entitled to receive dividend equivalents
on the units or other Share equivalents subject to the Award based on dividends actually declared and paid on outstanding Shares. Dividends
and dividend equivalents on Performance-Based Awards will be subject to the same terms and conditions, including vesting conditions and
the achievement of any applicable performance goals, as the original Award. The additional terms of any such dividend equivalents will
be as set forth in the applicable Award Agreement, including any additional restrictions and whether such dividend equivalents will be
credited with interest or deemed to be reinvested in additional units or Share equivalents. Any Shares issued or issuable during the term
of this Plan as the result of the reinvestment of dividends or the deemed reinvestment of dividend equivalents in connection with an Award
or a Prior Plan Award shall be counted against, and replenish upon any subsequent forfeiture, the Plan&rsquo;s share reserve as provided
in Section&nbsp;4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(i)&emsp;<U>Extension of Termination Date</U>.
If a Participant would otherwise be precluded from exercising an Option or SAR prior to the expiration of its scheduled term or prior
to its termination following the termination of the Participant&rsquo;s Service solely because the issuance of the Shares upon such exercise
would violate applicable registration requirements under the Securities Act, then the Committee may provide that the period during which
the Option or SAR may be exercised and the termination date of the Option or SAR shall be extended until the later of (i)&nbsp;the date
that is 30 days after the exercise of the Option or SAR would no longer violate the registration requirements of the Securities Act, or
(ii)&nbsp;the end of the applicable post-termination exercise period, but in no event later than the scheduled expiration date of the
Option as set forth in the applicable Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>7.&#8239;&emsp;<U>Stock Option Awards</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Type and Exercise Price</U>. The Agreement
pursuant to which an Option is granted shall specify whether the Option is an Incentive Stock Option or a Non-Statutory Stock Option.
The exercise price at which each Share subject to an Option may be purchased shall be determined by the Committee and set forth in the
Agreement, and shall not be less than the Fair Market Value of a Share on the Grant Date, except in the case of Substitute Awards (to
the extent consistent with Code Section&nbsp;409A and, in the case of Incentive Stock Options, Code Section&nbsp;424).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Payment of Exercise Price</U>. The
purchase price of the Shares with respect to which an Option is exercised shall be payable in full at the time of exercise. The purchase
price may be paid in cash or in such other manner as the Committee may permit, including by payment under a broker-assisted sale and remittance
program acceptable to the Committee or by withholding Shares otherwise issuable to the Participant upon exercise of the Option or by delivery
to the Company of Shares (by actual delivery or attestation) already owned by the Participant (in each case, such Shares having a Fair
Market Value as of the date the Option is exercised equal to the purchase price of the Shares being purchased).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;<U>Exercisability and Expiration</U>.
Each Option shall be exercisable in whole or in part on the terms provided in the Agreement. No Option shall be exercisable at any time
after its scheduled expiration. When an Option is no longer exercisable, it shall be deemed to have terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;<U>Incentive Stock Options</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;An Option will constitute an Incentive
Stock Option only if the Participant receiving the Option is an Employee who is not a Global Service Provider, and only to the extent
that (i)&nbsp;it is so designated in the applicable Agreement and (ii)&nbsp;the aggregate Fair Market Value (determined as of the Option&rsquo;s
Grant Date) of the Shares with respect to which Incentive Stock Options held by the Participant first become exercisable in any calendar
year (under the Plan and all other plans of the Company and its Affiliates) does not exceed $100,000. To the extent an Option granted
to a Participant exceeds this limit, the Option shall be treated as a Non-Statutory Stock Option. The maximum number of Shares that may
be issued upon the exercise of Incentive Stock Options shall equal the maximum number of Shares that may be the subject of Awards and
issued under the Plan as provided in the first sentence of Section&nbsp;4(a)&nbsp;subject to adjustment as provided in Section&nbsp;12(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;No Participant may receive an Incentive
Stock Option under the Plan if, immediately after the grant of such Award, the Participant would own (after application of the rules&nbsp;contained
in Code Section&nbsp;424(d)) Shares possessing more than 10% of the total combined voting power of all classes of stock of the Company
or an Affiliate, unless (i)&nbsp;the option price for that Incentive Stock Option is at least 110% of the Fair Market Value of the Shares
subject to that Incentive Stock Option on the Grant Date and (ii)&nbsp;that Option will expire no later than five years after its Grant
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&emsp;For purposes of continued Service by
a Participant who has been granted an Incentive Stock Option, no approved leave of absence may exceed three months unless reemployment
upon expiration of such leave is provided by statute or contract. If reemployment is not so provided, then on the date six months following
the first day of such leave, any Incentive Stock Option held by the Participant shall cease to be treated as an Incentive Stock Option
and shall be treated for tax purposes as a Non-Statutory Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(4)&emsp;If an Incentive Stock Option is exercised
after the expiration of the exercise periods that apply for purposes of Code Section&nbsp;422, or otherwise fails to qualify as an Incentive
Stock Option, such Option shall thereafter be treated as a Non-Statutory Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(5)&emsp;The Agreement covering an Incentive Stock
Option shall contain such other terms and provisions that the Committee determines necessary to qualify the Option as an Incentive Stock
Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>8.&#8239;&emsp;<U>Stock Appreciation Rights</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Nature of Award</U>. An Award of Stock
Appreciation Rights shall be subject to such terms and conditions as are determined by the Committee, and shall provide a Participant
the right to receive upon exercise of the SAR all or a portion of the excess of (i)&nbsp;the Fair Market Value as of the date of exercise
of the SAR of the number of Shares as to which the SAR is being exercised, over (ii)&nbsp;the aggregate exercise price for such number
of Shares. The per Share exercise price for any SAR Award shall be determined by the Committee and set forth in the applicable Agreement,
and shall not be less than the Fair Market Value of a Share on the Grant Date, except in the case of Substitute Awards (to the extent
consistent with Code Section&nbsp;409A).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Exercise of SAR</U>. Each SAR may
be exercisable in whole or in part at the times, on the terms and in the manner provided in the Agreement. No SAR shall be exercisable
at any time after its scheduled expiration. When a SAR is no longer exercisable, it shall be deemed to have terminated. Upon exercise
of a SAR, payment to the Participant shall be made at such time or times as shall be provided in the Agreement in the form of cash, Shares
or a combination of cash and Shares as determined by the Committee. The Agreement may provide for a limitation upon the amount or percentage
of the total appreciation on which payment (whether in cash and/or Shares) may be made in the event of the exercise of a SAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>9.&#8239;&emsp;<U>Restricted Stock Awards</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Vesting and Consideration</U>. Shares
subject to a Restricted Stock Award shall be subject to vesting conditions, and the corresponding lapse of forfeiture conditions and other
restrictions, based on such factors and occurring over such period of time as the Committee may determine in its discretion. The Committee
may provide whether any consideration other than Services must be received by the Company or any Affiliate as a condition precedent to
the grant of a Restricted Stock Award, and may correspondingly provide for Company reacquisition or repurchase rights if such additional
consideration has been required and some or all of a Restricted Stock Award does not vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Shares Subject to Restricted Stock
Awards</U>. Unvested Shares subject to a Restricted Stock Award shall be evidenced by a book-entry in the name of the Participant with
the Company&rsquo;s transfer agent or by one or more Stock certificates issued in the name of the Participant. Any such Stock certificate
shall be deposited with the Company or its designee, together with an assignment separate from the certificate, in blank, signed by the
Participant, and bear an appropriate legend referring to the restricted nature of the Restricted Stock evidenced thereby. Any book-entry
shall be subject to transfer restrictions and accompanied by a similar legend. Upon the vesting of Shares of Restricted Stock and the
corresponding lapse of the restrictions and forfeiture conditions, and any necessary conditions precedent to the release of vested Shares
(such as satisfaction of tax withholding obligations) have been satisfied, the corresponding transfer restrictions and restrictive legend
will be removed from the book-entry evidencing such Shares or the certificate evidencing such Shares, and any such certificate shall be
delivered to the Participant. Such vested Shares may, however, remain subject to additional restrictions as provided in Section&nbsp;18(c).
Except as otherwise provided in the Plan or an applicable Agreement, a Participant with a Restricted Stock Award shall have all the rights
of a shareholder, including the right to vote the Shares of Restricted Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>10.&#8239;&#8239;&#8239;<U>Stock Unit Awards</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Vesting and Consideration</U>. A Stock
Unit Award shall be subject to vesting conditions, and the corresponding lapse of forfeiture conditions and other restrictions, based
on such factors and occurring over such period of time as the Committee may determine in its discretion. If a Stock Unit Award is a Performance-Based
Award, the extent to which the goals are achieved over the specified performance period shall determine the number of Stock Units that
will be earned and eligible to vest, which may be greater or less than the target number of Stock Units stated in the Agreement. The Committee
may provide whether any consideration other than Services must be received by the Company or any Affiliate as a condition precedent to
the settlement of a Stock Unit Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Settlement of Award</U>. Following
the vesting of a Stock Unit Award, and the Committee&rsquo;s determination that any necessary conditions precedent to the settlement of
the Award (such as satisfaction of tax withholding obligations and compliance with applicable legal requirements) have been satisfied,
settlement of the Award and payment to the Participant shall be made at such time or times in the form of cash, Shares (which may themselves
be considered Restricted Stock under the Plan subject to restrictions on transfer and forfeiture conditions) or a combination of cash
and Shares as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>11.&emsp;<U>Cash-Based and Other Stock-Based
Awards</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Cash Incentive Awards</U>. A Cash
Incentive Award may be considered a Performance-Based Award, and may be granted to any Participant in such amounts and upon such terms
and at such times as shall be determined by the Committee, and may be denominated in units that have a dollar value established by the
Committee as of the Grant Date. Following the completion of the applicable performance period and the vesting of a Cash Incentive Award,
payment of the settlement amount of the Award to the Participant shall be made at such time or times in the form of cash, Shares or other
forms of Awards under the Plan (valued for these purposes at their grant date fair value) or a combination of cash, Shares and other forms
of Awards as determined by the Committee and specified in the applicable Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Other Stock-Based Awards</U>. The
Committee may from time to time grant Stock and other Awards that are valued by reference to and/or payable in whole or in part in Shares
under the Plan. The Committee, in its sole discretion, shall determine the terms and conditions of such Awards, which shall be consistent
with the terms and purposes of the Plan. The Committee may, in its sole discretion, direct the Company to issue Shares subject to restrictive
legends and/or stop transfer instructions that are consistent with the terms and conditions of the Award to which the Shares relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>12.&emsp;<U>Changes in Capitalization and Other
Corporate Events</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Adjustments for Changes in Capitalization</U>.
In the event of any equity restructuring (within the meaning of FASB ASC Topic 718 - <I>Stock Compensation</I>) that causes the per share
value of Shares to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization through an extraordinary
dividend, the Committee shall make such adjustments as it deems equitable and appropriate to (i)&nbsp;the aggregate number and kind of
Shares or other securities issued or reserved for issuance under the Plan, (ii)&nbsp;the number and kind of Shares or other securities
subject to outstanding Awards, (iii)&nbsp;the exercise price of outstanding Options and SARs, and (iv)&nbsp;any maximum limitations prescribed
by the Plan with respect to certain types of Awards or the grants to individuals of certain types of Awards. In the event of any other
change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete liquidation of the Company,
such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate and equitable by the Committee
to prevent dilution or enlargement of rights of Participants. In either case, any such adjustment shall be conclusive and binding for
all purposes of the Plan. No adjustment shall be made pursuant to this Section&nbsp;12(a)&nbsp;in connection with the conversion of any
convertible securities of the Company, or in a manner that would cause Incentive Stock Options to violate Section&nbsp;422(b)&nbsp;of
the Code or cause an Award to be subject to adverse tax consequences under Code Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Corporate Transactions</U>. Unless
otherwise provided in an applicable Agreement, in the event of a Change in Control that involves a Corporate Transaction, the Board or
the Committee shall take one or more of the following actions with respect to outstanding Awards, which actions may vary among individual
Participants and among Awards held by an individual Participant, and are conditioned in each case upon the closing or completion of the
Corporate Transaction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;<I><U>Continuation, Assumption or Replacement
of Awards</U></I>. Arrange for the surviving or successor entity (or its Parent) to continue, assume or replace Awards outstanding as
of the date of the Corporate Transaction (with such adjustments as may be required or permitted by Section&nbsp;12(a)), and such Awards
or replacements therefor to remain outstanding and be governed by their respective terms. A surviving or successor entity may elect to
continue, assume or replace only some Awards or portions of Awards. For purposes of this Section&nbsp;12(b)(1), an Award shall be considered
assumed or replaced if, in connection with the Corporate Transaction and in a manner consistent with Code Sections 409A and 424, either
(i)&nbsp;the contractual obligations represented by the Award are expressly assumed by the surviving or successor entity (or its Parent)
with appropriate adjustments to the number and type of securities subject to the Award and the exercise price thereof that preserves the
intrinsic value of the Award existing at the time of the Corporate Transaction, or (ii)&nbsp;the Participant has received a comparable
equity-based award that preserves the intrinsic value of the Award existing at the time of the Corporate Transaction and is subject to
substantially similar terms and conditions as the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;<I><U>Acceleration</U></I>. Accelerate
the vesting (and exercisability, if applicable) of (i)&nbsp;some or all outstanding Options and SARs so that such Awards may be exercised
in full for such limited period of time prior to the effective time of the Corporate Transaction as is deemed fair and equitable by the
Board or Committee, with such Awards then terminating to the extent not exercised at the effective time of the Corporate Transaction,
and (ii)&nbsp;some or all outstanding Full Value Awards or Cash Incentive Awards immediately prior to the effective time of the Corporate
Transaction. In the case of Performance-Based Awards, the number of Shares or the amount of a Cash Incentive Award subject to such accelerated
vesting shall be based on a determination by the Board or Committee of the degree to which any performance-based vesting or payment conditions
will be deemed satisfied. The Board or Committee shall provide written notice of the period of accelerated exercisability of Options and
SARs to all affected Participants, and any exercise of such accelerated Awards shall be conditioned upon the consummation of the Corporate
Transaction and shall be effective only immediately before the effective time of the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&emsp;<I><U>Payment for Awards</U></I>. Cancel
some or all outstanding Awards at or immediately prior to the effective time of the Corporate Transaction in exchange for payments to
the holders as provided in this Section&nbsp;12(b)(3). The payment for any Award canceled shall be in an amount equal to the difference,
if any, between (i)&nbsp;the fair market value (as determined in good faith by the Board or Committee) of the consideration that would
otherwise be received in the Corporate Transaction for the number of Shares remaining subject to the Award, and (ii)&nbsp;the aggregate
exercise price (if any) for the number of Shares remaining subject to such Award. If the amount determined pursuant to clause (i)&nbsp;of
the preceding sentence is less than or equal to the amount determined pursuant to clause (ii)&nbsp;of the preceding sentence with respect
to any Award, such Award may be canceled without payment of any kind to the affected Participant. The payment for any canceled Cash Incentive
Award that was to be settled in Shares shall be in an amount equal to the settlement amount that was to form the basis for the calculation
of the number of Shares to be issued. In the case of Performance-Based Awards, the number of Shares remaining subject to an Award or the
settlement amount of a Cash Incentive Award shall be calculated based on a determination by the Board or Committee of the degree to which
any performance-based vesting or payment conditions will be deemed satisfied. Payment of any amount under this Section&nbsp;12(b)(3)&nbsp;shall
be made in such form (including in shares of the surviving or successor entity or its Parent), on such terms and subject to such conditions
as the Board or Committee determines in its discretion, which may or may not be the same as the form, terms and conditions applicable
to payments to the Company&rsquo;s shareholders in connection with the Corporate Transaction, and may, in the discretion of the Board
or Committee, include subjecting such payments to vesting conditions comparable to those of the Award canceled, subjecting such payments
to escrow or holdback terms comparable to those imposed upon the Company&rsquo;s shareholders under the Corporate Transaction, or calculating
and paying the present value of payments that would otherwise be subject to escrow or holdback terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(4)&emsp;<I><U>Termination After a Corporate Transaction</U></I>.
Provide that with respect to any Award that is continued, assumed or replaced under the circumstances described in Section&nbsp;12(b)(1),
if within 18 months after the Corporate Transaction the Participant experiences an involuntary termination of Service from the surviving
or successor entity (or its Parent or subsidiary) for reasons other than Cause, then (i)&nbsp;outstanding Options and SARs issued to the
Participant that are not yet fully exercisable shall immediately become exercisable in full and shall remain exercisable for one year
following the Participant&rsquo;s termination of Service, and (ii)&nbsp;any Full Value Awards that are not yet fully vested shall immediately
vest in full, with vesting in full for a Performance-Based Award determined as provided in Section&nbsp;12(b)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(5)&emsp;<I><U>Adjustments to Awards</U></I>.
Make such adjustments to some or all outstanding Awards as may be required or permitted by Sections 12(a)&nbsp;and 6(g).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;<U>Other Change in Control</U>. In connection
with a Change in Control that does not involve a Corporate Transaction, the Board or Committee may provide (in the applicable Agreement
or otherwise) for one or more of the following: (i)&nbsp;that any Award shall become fully vested (and exercisable, if applicable) upon
the occurrence of the Change in Control or upon the involuntary termination of the Participant without Cause within 18 months of the Change
in Control, (ii)&nbsp;that any Option or SAR shall remain exercisable during all or some specified portion of its remaining term, or (iii)&nbsp;that
Awards shall be canceled in exchange for payments in a manner similar to that provided in Section&nbsp;12(b)(3). The Committee will not
be required to treat all Awards similarly in such circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;<U>Dissolution or Liquidation</U>. Unless
otherwise provided in an applicable Agreement, in the event the shareholders of the Company approve the complete dissolution or liquidation
of the Company, all outstanding Awards will terminate immediately prior to the consummation of any such proposed action. The Committee
will notify each Participant as soon as practicable of such pending termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&emsp;<U>Limitation on Change in Control Payments</U>.
If any payments to a Participant pursuant to Awards made under this Plan (including, for this purpose, the acceleration of the vesting
and exercisability of any Award or the payment of cash or other property in exchange for all or part of any Award), taken together with
any payments or benefits otherwise paid or distributed to the Participant by the Company or any corporation that is a member of an &ldquo;affiliated
group&rdquo; (as defined in Section&nbsp;1504 of the Code without regard to Section&nbsp;1504(b)&nbsp;of the Code) of which the Company
is a member (the &ldquo;other arrangements&rdquo;) would collectively constitute a &ldquo;parachute payment&rdquo; (as defined in Section&nbsp;280G(b)(2)&nbsp;of
the Code), and if the net after-tax amount of such parachute payment to the Participant is less than what the net after-tax amount to
the Participant would be if the aggregate payments and benefits otherwise constituting the parachute payment were limited to three times
the Participant&rsquo;s &ldquo;base amount&rdquo; (as defined in Section&nbsp;280G(b)(3)&nbsp;of the Code) less $1.00, then the aggregate
payments and benefits otherwise constituting the parachute payment shall be reduced to an amount that shall equal three times the Participant&rsquo;s
base amount, less $1.00. Should such a reduction in payments and benefits be required, the Participant shall be entitled, subject to the
following sentence, to designate those payments and benefits under this Plan or the other arrangements that will be reduced or eliminated
(including, as applicable, a reduction in the number of Shares subject to Awards that will vest on an accelerated basis) so as to achieve
the specified reduction in aggregate payments and benefits to the Participant and avoid characterization of such aggregate payments and
benefits as a parachute payment. To the extent that the Participant&rsquo;s ability to make such a designation would cause any of the
payments and benefits to become subject to any additional tax under Code Section&nbsp;409A, or if the Participant fails to make such a
designation within the time prescribed by the Committee, then the Committee shall achieve the necessary reduction in such payments and
benefits in the following order: (1)&nbsp;by reducing or eliminating the portion of the payments and benefits that are payable in cash;
(2)&nbsp;by reducing or eliminating equity awards (or the accelerated vesting thereof) that are included as parachute payments; (3)&nbsp;by
reducing or eliminating any non-cash, non-equity benefits; in each case, within each category, in reverse order beginning with payments
and benefits which are to be paid or provided the furthest in time from the date of the Committee&rsquo;s determination. For purposes
of this Section&nbsp;12(e), a net after-tax amount shall be determined by taking into account all applicable income, excise and employment
taxes, whether imposed at the federal, state or local level, including the excise tax imposed under Section&nbsp;4999 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt"><B>13.&emsp;<U>Plan
Participation and Service Provider Status</U>.</B></FONT> Status as a Service Provider shall not be construed as a commitment that any
Award will be made under the Plan to that Service Provider or to eligible Service Providers generally. Nothing in the Plan or in any Agreement
or related documents shall confer upon any Service Provider or Participant any right to continued Service with the Company or any Affiliate,
nor shall it interfere with or limit in any way any right of the Company or any Affiliate to terminate the person&rsquo;s Service at any
time with or without Cause or change such person&rsquo;s compensation, other benefits, job responsibilities or title.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt"><B>14.&emsp;<U>Tax
Withholding</U>.</B></FONT> The Company or any Affiliate, as applicable, shall have the right to (i)&nbsp;withhold from any cash payment
under the Plan or any other compensation owed to a Participant an amount sufficient to cover any required withholding taxes related to
the grant, vesting, exercise or settlement of an Award, and (ii)&nbsp;require a Participant or other person receiving Shares under the
Plan to pay a cash amount sufficient to cover any required withholding taxes before actual receipt of those Shares. In lieu of all or
any part of a cash payment from a person receiving Shares under the Plan, the Committee may permit the individual to cover all or any
part of the required withholdings (up to the Participant&rsquo;s maximum individual statutory tax withholding rate) through a reduction
in the number of Shares delivered or a delivery or tender to the Company of Shares held by the Participant or other person, in each case
valued in the same manner as used in computing the withholding taxes under applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>15.&emsp;<U>Duration, Amendment and Termination
of the Plan</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Duration of the Plan</U>. The Plan
shall remain in effect until all Shares subject to it shall be distributed, the Plan is terminated pursuant to Section&nbsp;15(c), or
the tenth anniversary of the Amended and Restated Effective Date, whichever occurs first (the &ldquo;Termination Date&rdquo;). Awards
made before the Termination Date shall continue to be outstanding in accordance with their terms and the terms of the Plan unless otherwise
provided in the applicable Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ensp;(b)&#8239;<U>Amendment and Termination of
the Plan</U>. The Board may at any time terminate, suspend or amend the Plan. The Company shall submit any amendment of the Plan to its
shareholders for approval only to the extent required by applicable laws or regulations or the rules&nbsp;of any securities exchange on
which the Shares may then be listed. No termination, suspension, or amendment of the Plan may materially impair the rights of any Participant
under a previously granted Award without the Participant&rsquo;s consent, unless such action is necessary to comply with applicable law
or stock exchange rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;<U>Amendment of Awards</U>. Subject to
Section&nbsp;15(e), the Committee may unilaterally amend the terms of any Agreement previously granted, except that no such amendment
may materially impair the rights of any Participant under the applicable Award without the Participant&rsquo;s consent, unless such amendment
is necessary to comply with applicable law or stock exchange rules&nbsp;or any compensation recovery policy as provided in Section&nbsp;18(i)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;<U>No Option or SAR Repricing</U>. Except
as provided in Section&nbsp;12(a), no Option or Stock Appreciation Right Award granted under the Plan may be (i)&nbsp;amended to decrease
the exercise price thereof, (ii)&nbsp;cancelled in conjunction with the grant of any new Option or Stock Appreciation Right Award with
a lower exercise price, (iii)&nbsp;cancelled in exchange for cash, other property or the grant of any Full Value Award at a time when
the per share exercise price of the Option or Stock Appreciation Right Award is greater than the current Fair Market Value of a Share,
or (iv)&nbsp;otherwise subject to any action that would be treated under accounting rules&nbsp;as a &ldquo;repricing&rdquo; of such Option
or Stock Appreciation Right Award, unless such action is first approved by the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt"><B>16.&emsp;<U>Substitute
Awards</U>.</B></FONT> The Committee may also grant Awards under the Plan in substitution for, or in connection with the assumption of,
existing awards granted or issued by another corporation and assumed or otherwise agreed to be provided for by the Company pursuant to
or by reason of a transaction involving a merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation
to which the Company or an Affiliate is a party. The terms and conditions of the Substitute Awards may vary from the terms and conditions
set forth in the Plan to the extent that the Committee at the time of the grant may deem appropriate to conform, in whole or in part,
to the provisions of the awards in substitution for which they are granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>17.&emsp;<U>Performance-Based Awards</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Performance-Based Awards</U>. If an
Award is a Performance-Based Award, then the lapsing of restrictions thereon and the distribution of cash, Shares or other property pursuant
thereto, as applicable, shall be subject to the achievement over the applicable performance period of one or more performance goals based
on one or more of the performance measures specified in Section&nbsp;17(b). The Committee will select the applicable performance measure(s)&nbsp;and
specify the performance goal(s)&nbsp;based on those performance measures for any performance period, specify in terms of an objective
formula or standard the method for calculating the amount payable to a Participant if the performance goal(s)&nbsp;are satisfied, and
certify the degree to which applicable performance goals have been satisfied and any amount that vests and is payable in connection with
an Award subject to this Section&nbsp;17. In specifying the performance goals applicable to any performance period, the Committee may
provide that one or more objectively determinable adjustments shall be made to the performance measures on which the performance goals
are based, which may include adjustments that would cause such measures to be considered &ldquo;non-GAAP financial measures&rdquo; within
the meaning of Rule&nbsp;101 under Regulation G promulgated by the Securities and Exchange Commission, including adjustments for events
that are unusual in nature or infrequently occurring, such as a Change in Control, acquisitions, divestitures, restructuring activities
or asset write-downs, or for changes in applicable tax laws or accounting principles. The Committee may also adjust performance measures
for a performance period in connection with an event described in Section&nbsp;12(a)&nbsp;to prevent the dilution or enlargement of a
Participant&rsquo;s rights with respect to Performance-Based Award. The Committee may adjust any amount determined to be otherwise payable
in connection with such an Award. The Committee may also provide, in an Agreement or otherwise, that the achievement of specified performance
goals in connection with an Award subject to this Section&nbsp;17 may be waived upon the death or Disability of the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>18.&emsp;<U>Other Provisions</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a)&emsp;<U>Unfunded Plan</U>. The Plan shall
be unfunded and the Company shall not be required to segregate any assets that may at any time be represented by Awards under the Plan.
Neither the Company, its Affiliates, the Committee, nor the Board shall be deemed to be a trustee of any amounts to be paid under the
Plan nor shall anything contained in the Plan or any action taken pursuant to its provisions create or be construed to create a fiduciary
relationship between the Company and/or its Affiliates, and a Participant. To the extent any person has or acquires a right to receive
a payment in connection with an Award under the Plan, this right shall be no greater than the right of an unsecured general creditor of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&emsp;<U>Limits of Liability</U>. Except as
may be required by law, neither the Company nor any member of the Board or of the Committee, nor any other person participating (including
participation pursuant to a delegation of authority under Section&nbsp;3(c)&nbsp;of the Plan) in any determination of any question under
the Plan, or in the interpretation, administration or application of the Plan, shall have any liability to any party for any action taken,
or not taken, in good faith under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&emsp;<U>Compliance with Applicable Legal Requirements
and Company Policies</U>. No Shares distributable pursuant to the Plan shall be issued and delivered unless the issuance of the Shares
complies with all applicable legal requirements, including compliance with the provisions of applicable state and federal securities laws,
and the requirements of any securities exchanges on which the Company&rsquo;s Shares may, at the time, be listed. The Committee may, in
its discretion, to the extent permitted by Code Section&nbsp;409A, if applicable, suspend the right to exercise Options or SARs to be
settled in Shares, or delay the payment or settlement of any other Awards to be paid or settled in Shares, during any period in which
the issuance of such Shares would not be in compliance with any applicable legal or securities exchange requirements. During any period
in which the offering and issuance of Shares under the Plan are not registered under federal or state securities laws, Participants shall
acknowledge that they are acquiring Shares under the Plan for investment purposes and not for resale, and that Shares may not be transferred
except pursuant to an effective registration statement under, or an exemption from the registration requirements of, such securities laws.
Any book-entry or stock certificate evidencing Shares issued under the Plan that are subject to such securities law restrictions shall
be accompanied by or bear an appropriate restrictive legend or stop transfer instruction. Notwithstanding any other provision of this
Plan, the acquisition, holding or disposition of Shares acquired pursuant to the Plan shall in all events be subject to compliance with
applicable Company policies, including those relating to insider trading, pledging or hedging transactions, minimum post-vesting holding
periods and stock ownership guidelines, and to forfeiture or recovery of compensation as provided in Section&nbsp;18(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d)&emsp;<U>Other Benefit and Compensation Programs</U>.
Payments and other benefits received by a Participant under an Award made pursuant to the Plan shall not be deemed a part of a Participant&rsquo;s
regular, recurring compensation for purposes of the termination, indemnity or severance pay laws of any country or state and shall not
be included in, nor have any effect on, the determination of benefits under any other employee benefit plan, contract or similar arrangement
provided by the Company or an Affiliate unless expressly so provided by such other plan, contract or arrangement, or unless the Committee
expressly determines that an Award or portion of an Award should be included to accurately reflect competitive compensation practices
or to recognize that an Award has been made in lieu of a portion of competitive cash compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(e)&emsp;<U>Governing Law</U>. To the extent that
federal laws do not otherwise control, the Plan and all determinations made and actions taken pursuant to the Plan shall be governed by
the laws of the State of Minnesota without regard to its conflicts-of-law principles and shall be construed accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f)&emsp;<U>Severability</U>. If any provision
of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the
Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(g)&emsp;<U>Code Section&nbsp;409A</U>. It is
intended that all Awards under the Plan will be exempt from, or will comply with, Code Section&nbsp;409A, and to the maximum extent permitted
the Awards the Plan will be limited, construed and interpreted in accordance with this intent. Notwithstanding anything to the contrary
in the Plan or any Agreement, with respect to any Award that constitutes a deferral of compensation subject to Code Section&nbsp;409A:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;If any amount is payable under such Award
upon a termination of Service, a termination of Service will be deemed to have occurred only at such time as the Participant has experienced
a &ldquo;separation from service&rdquo; as such term is defined for purposes of Code Section&nbsp;409A; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;If any amount shall be payable with respect
to any such Award as a result of a Participant&rsquo;s &ldquo;separation from service&rdquo; at such time as the Participant is a &ldquo;specified
employee&rdquo; within the meaning of Code Section&nbsp;409A, then no payment shall be made, except as permitted under Code Section&nbsp;409A,
prior to the first business day after the earlier of (i)&nbsp;the date that is six months after the Participant&rsquo;s separation from
Service or (ii)&nbsp;the Participant&rsquo;s death. Unless the Committee has adopted a specified employee identification policy as contemplated
by Code Section&nbsp;409A, specified employees will be identified in accordance with the default provisions specified under Code Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each amount to be paid under an Award or this
Plan shall be construed as a separate and distinct payment for purposes of Code Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">None of the Company, the Committee or any other
person involved with the administration of this Plan shall (i)&nbsp;in any way be responsible for ensuring the exemption of any Award
from, or compliance by any Award with, the requirements of Code Section&nbsp;409A, (ii)&nbsp;have any duty or obligation to design or
administer the Plan or Awards granted thereunder in a manner that minimizes a Participant&rsquo;s tax liabilities, including the avoidance
of any additional tax liabilities under Code Section&nbsp;409A; or (iii)&nbsp;have any liability to any Participant for any such tax liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(h)&emsp;<U>Rule&nbsp;16b-3</U>. It is intended
that the Plan and all Awards granted pursuant to it shall be administered by the Committee so as to permit the Plan and Awards to comply
with Exchange Act Rule&nbsp;16b-3. If any provision of the Plan or of any Award would otherwise frustrate or conflict with the intent
expressed in this Section&nbsp;18(h), that provision to the extent possible shall be interpreted and deemed amended in the manner determined
by the Committee so as to avoid the conflict. To the extent of any remaining irreconcilable conflict with this intent, the provision shall
be deemed void as applied to Participants subject to Section&nbsp;16 of the Exchange Act to the extent permitted by law and in the manner
deemed advisable by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(i)&#8239;&emsp;<U>Forfeiture and Compensation Recovery</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&emsp;The Committee may specify in an Agreement
that the Participant&rsquo;s rights, payments, and benefits with respect to an Award will be subject to reduction, cancellation, forfeiture
or recovery by the Company upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance
conditions of an Award. Such events may include termination of Service for Cause, violation of any material Company or Affiliate policy,
breach of noncompetition, non-solicitation or confidentiality provisions that apply to the Participant, a determination that the payment
of the Award was based on an incorrect determination that financial or other criteria were met or other conduct by the Participant that
is detrimental to the business or reputation of the Company or its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&emsp;Awards and any compensation associated
therewith are subject to forfeiture, recovery by the Company or other action pursuant to any compensation recovery policy adopted by the
Board or the Committee at any time, as amended from time to time, which includes but is not limited to any compensation recovery policy
adopted by the Board or the Committee including in response to the requirements of Section&nbsp;10D of the Exchange Act, the SEC&rsquo;s
final rules&nbsp;thereunder, and any applicable listing rules&nbsp;or other implementing rules&nbsp;and regulations thereunder, or as
otherwise required by law. Any Agreement will be automatically unilaterally amended to comply with any such compensation recovery policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm2515767d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><IMG SRC="tm2515767d1_ex99-1img001.jpg" ALT=""></TD>
  <TD STYLE="text-align: right; width: 50%; vertical-align: top"><IMG SRC="tm2515767d1_ex99-1img002.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>FOR IMMEDIATE RELEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Protolabs Appoints Suresh Krishna as President
and CEO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Reaffirms Second Quarter 2025 Outlook</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MINNEAPOLIS &ndash; (BUSINESS WIRE) &ndash; May&nbsp;21, 2025 &ndash;
Proto Labs,&nbsp;Inc. (&quot;Protolabs&quot; or the &quot;Company&quot;) (NYSE: PRLB), the world&rsquo;s leading provider of digital manufacturing
services, today announced its Board of Directors has appointed Suresh Krishna as President and Chief Executive Officer and a member of
the Board of Directors, effective immediately. Krishna most recently served as President and Chief Executive Officer at Northern Tool
+ Equipment, a manufacturer and retailer of tools and commercial equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Krishna succeeds Rob Bodor, who has entered into a consulting arrangement
with the Company to facilitate a seamless transition. With Krishna as CEO, the Board believes Protolabs is well-positioned for success
thanks to its strategy as a single manufacturing source - from prototyping to production - for product developers, engineers and supply
chain teams across the globe. At Northern Tool + Equipment, he was instrumental in expanding the company&rsquo;s customer-centric culture
and customer base and was the catalyst of accelerating its growth strategy through operational and supply chain optimizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rainer Gawlick, Chairman of Protolabs&rsquo; Board of Directors said,
 &ldquo;Under Rob&rsquo;s leadership, Protolabs has expanded its capabilities, enhanced its manufacturing processes, significantly broadened
the Protolabs Network and driven business-wide organizational improvements, all to better serve its customers. With the solid foundation
that Rob helped establish, the Company is well-prepared to enter its next phase of growth. We thank Rob for his dedication to Protolabs
and its customers and wish him well in his next chapter.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gawlick continued, &ldquo;Protolabs has started the year strong, and
we are pleased to welcome Suresh as the Company&rsquo;s new CEO. With a 30-year track record of overseeing profitable growth and shareholder
value creation at manufacturing companies, we are confident that he has the right skills and experience to build on the Company&rsquo;s
positive momentum. He will take Protolabs to the next level by growing our customer loyalty and share, accelerating the execution of our
production expansion initiatives and continuing to drive profitable growth through our unique digital manufacturing model. Importantly,
Suresh brings fresh perspectives and a talent for implementing innovative growth strategies, which will be key to advancing our winning
strategy and delivering results.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Krishna said, &ldquo;I&rsquo;m honored to join Protolabs as its next
CEO. This is an important time as the Company works to expand its offerings and gain a larger share of the $100 billion digital manufacturing
market. Protolabs has an amazing team, best in class production times and a key competitive advantage as the only digital manufacturer
that combines in-house digital manufacturing with a network of manufacturing partners. This next chapter for the Company is going to be
an extraordinary one, and I am thrilled to be leading the talented Protolabs team forward.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2515767d1_ex99-1img003.jpg" ALT="" STYLE="height: 34px; width: 850px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><IMG SRC="tm2515767d1_ex99-1img001.jpg" ALT=""></TD>
  <TD STYLE="text-align: right; width: 50%; vertical-align: top"><IMG SRC="tm2515767d1_ex99-1img002.jpg" ALT=""></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bodor said, &ldquo;It&rsquo;s been a privilege to have led the Protolabs
team over the past four years. Together, we have advanced the Company&rsquo;s position as a leading prototype manufacturer serving some
of the most innovative companies in the world across a range of industries. Core to our success has been our unwavering commitment to
quality and our customers, who have rewarded us with their loyalty and business. I look forward to seeing Protolabs continue to advance
and achieve its full potential.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Second Quarter 2025 Outlook</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company reaffirms its previously provided outlook for the second
quarter of 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the second quarter of 2025, the Company expects to generate revenue
between $124.0 million and $132.0 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company expects second quarter 2025 diluted net income per share
between $0.11 and $0.19, and non-GAAP diluted net income per share between $0.30 and $0.38. See &quot;Non-GAAP Financial Measure&quot;
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Suresh Krishna</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suresh Krishna is an experienced operating executive and business leader
with a 30-year track record of generating profitable growth. Krishna most recently served as President and Chief Executive Officer of
Northern Tool + Equipment, a manufacturer and retailer of tools and commercial equipment serving millions of customers annually. At Northern
Tool, he led the workforce through a business and cultural transformation with a focus on customer-centric innovation, operational excellence
and growth. Prior to that, Krishna held operations and leadership roles at companies such as Sleep Number Corporation, Polaris Industries
and UTC Fire&nbsp;&amp; Security. Krishna holds a bachelor&rsquo;s degree in mechanical engineering from the National Institute of Technology
(Tiruchirappalli, Tamil Nadu,&nbsp;India) and a master&rsquo;s in business administration from the Kellogg School of Management at Northwestern
University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Protolabs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Protolabs is the world&rsquo;s fastest manufacturing service enabling
companies across every industry to streamline production of quality parts throughout the entire product life cycle. From custom prototyping
to end-use production, we support product developers, engineers, and supply chain teams along every phase of their manufacturing journey.
Get started now at <U>protolabs.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2515767d1_ex99-1img003.jpg" ALT="" STYLE="height: 34px; width: 850px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><IMG SRC="tm2515767d1_ex99-1img001.jpg" ALT=""></TD>
  <TD STYLE="text-align: right; width: 50%; vertical-align: top"><IMG SRC="tm2515767d1_ex99-1img002.jpg" ALT=""></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Non-GAAP Financial Measure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has included non-GAAP net income per share, adjusted for
stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and benefits related to exit and disposal
activities (&ldquo;non-GAAP net income per share&rdquo;), in this press release to provide investors with additional information regarding
the Company&rsquo;s expected financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has provided below a reconciliation of GAAP to non-GAAP
net income per share, the most directly comparable measure calculated and presented in accordance with GAAP. This non-GAAP measure is
used by the Company&rsquo;s management and board of directors to understand and evaluate operating performance and trends, provide useful
measures for period-to-period comparisons of the Company&rsquo;s business, and in determining executive and senior management incentive
compensation. Accordingly, the Company believes that this non-GAAP measure provides useful information to investors and others in understanding
and evaluating operating results in the same manner as our management and board of directors. This non-GAAP financial measure should not
be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. This non-GAAP financial measure
excludes significant expenses and income that are required by GAAP to be recorded in our condensed consolidated financial statements and
are subject to inherent limitations. Investors should review the reconciliation of this non-GAAP financial measure to the comparable GAAP
financial measure that is included in this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Statements contained in this press release regarding matters that are
not historical or current facts are &ldquo;forward-looking statements&rdquo; within the meaning of The Private Securities Litigation Reform
Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs
to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described
in the &ldquo;Risk Factors&rdquo; section within reports filed with the SEC. Other unknown or unpredictable factors also could have material
adverse effects on Protolabs&rsquo; future results. The forward-looking statements included in this press release are made only as of
the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not
place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any
forward-looking statements to reflect subsequent events or circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2515767d1_ex99-1img003.jpg" ALT="" STYLE="height: 34px; width: 850px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><IMG SRC="tm2515767d1_ex99-1img001.jpg" ALT=""></TD>
  <TD STYLE="text-align: right; width: 50%; vertical-align: top"><IMG SRC="tm2515767d1_ex99-1img002.jpg" ALT=""></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proto Labs,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Reconciliation of GAAP to Non-GAAP Guidance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Q2 2025 Outlook</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Low</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">High</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">GAAP diluted net income per share</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.11</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.19</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Add back:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Stock-based compensation expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.16</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.16</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Amortization expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.03</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.03</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Unrealized (gain) loss on foreign currency</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total adjustments</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.19</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.19</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-GAAP diluted net income per share</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.30</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.38</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Protolabs</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ryan Johnsrud, 612-225-4873</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Manager &ndash; Investor Relations and FP&amp;A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ryan.johnsrud@protolabs.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Protolabs</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brent Renneke, 763-479-7704</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marketing Communications Manager</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>brent.renneke@protolabs.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2515767d1_ex99-1img003.jpg" ALT="" STYLE="height: 34px; width: 850px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>prlb-20250520.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa2M+bOdzZR+mYkxtmB7bRkq/yshjiQaXySbFYW2sYIB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:prlb="http://prlb.com/20250520" elementFormDefault="qualified" targetNamespace="http://prlb.com/20250520">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://prlb.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="prlb-20250520_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="prlb-20250520_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>prlb-20250520_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>prlb-20250520_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://prlb.com/role/Cover" xlink:href="prlb-20250520.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://prlb.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2515767d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2515767d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !4 3T# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)XTCFO\ PS T%O*[-*CE%0E@"IZC\:YG3]9\2Z98QV=O8R>5'G;NMF)Y)/\
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$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2515767d1_ex99-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2515767d1_ex99-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !5 * # 2(  A$! Q$!_\0
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%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2515767d1_ex99-1img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2515767d1_ex99-1img003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  @ RH# 2(  A$! Q$!_\0
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M1P,YQGC%>BT47 ****0!1110 5YU<VMV?%4F$E\MM7BF^Q_8V)=0%'F^?C
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);N[FL59)'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 20,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Proto Labs, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001443669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1939628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5540 Pioneer Creek Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Maple Plain<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">479-3680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.001 Per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRLB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2515767d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prlb.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>prlb-20250520.xsd</File>
    <File>prlb-20250520_lab.xml</File>
    <File>prlb-20250520_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2515767d1_8k.htm">tm2515767d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2515767d1_8k.htm": {
   "nsprefix": "prlb",
   "nsuri": "http://prlb.com/20250520",
   "dts": {
    "schema": {
     "local": [
      "prlb-20250520.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "prlb-20250520_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prlb-20250520_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2515767d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://prlb.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2515767d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2515767d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://prlb.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001104659-25-051610-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-051610-xbrl.zip
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MVO$H10'"T736AX94^P3C*DDC3 LO5W);VM$\B]8U(*!=$Y*6,"A0('<@+$6
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M$I378OO]\OJF:_E);M:;Y%\KG!*YY;]02P,$%     @ O8&U6BABUNE2!P
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MT0$/VQ\R6;@^'[U7D%(QZH9!,/;7U]:FTVD9T%0>N!=K= K]@OMKW!P8WAI
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MNY"^:HWHXYTES,0V _<8-4ML(]1K8_CJ" -1)A7$#YZU@>!/!L08Z2\SI+?
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MP!C1T^W\(\' "5]'L'"HE"^+%,GM6.-N:4'DJ$L<;VRO#Y5E)\<V,WF'[1%
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M1.]=> HA?J-\%/ 0<!\]RV;(D$B=^O))5KS2NJ[SJY<!C8"Y&TIP:P <O?H
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M1:.T9QCRPQ7"=$EA( 0S!TF\41C5R?"K;GN7<_Q\HN"I7LJBAJU:=;'#?'C
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M,!8B&"]0!=3XT-?#I!6/KIX[KH(,IZ#?"U9O$]^KVW%:M>7NK*ITX /N%LL
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M%Y&/!&U_P%"!J]/F49'DCCO+^7"+AZZH2MT^*\,V!UW;;FNG-!>"<\ KP/3
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M#4 E5QH\:"Q<67W8\9("R2*M$PB@,6_A@YPG$*]LUC;OR_8$<=YDAW>%-+2
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M.G]6Q^)'.M(>*'C,_"E-E_C JDORR2?3A&!RIKG$^<6OGB&F@>=Q[ 75&H-
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M;G$E >2E ,RV0?.HT6$C)L5@Q?-5S5:^V;92+*#D=P-K.V'8"%N?2[K+4J^
M78*+KEVD:#1"D>;X-QPD?HPDR.$(Q)0+#:9"7);N);4H6FCP9O=&4O?.+G3L
M6>'9CG];ZD@#^9(C1G!MO8S21F>6Z^&Q7 /S0FVYI)PD+7A?D:Z-%E\8N22'
MP*&<YJP&IST9 49_*+NF/.96S>5'%KT'"[K\R_90$3A:KQ^I&QSNGI^*2PF0
M#G >AP=JUM#.6#2T62-V'4[S!/L((W"P12*)%X8O^IOFXP<!PZ$OXAK6L?6H
MVY,<CUYX&WZN:A"PIB]&F*EPAR'6!,ZGOCMIEB=XRH>4D-O2<1$TU:G W*P^
MYVC;U"(OPR*_)>WF8QY*SZ861E3<%>:""NVJE=G98&D6JVIASCECIWC=Y3(E
M\N<K\:>@WKE)A1B#2B&)>EZ74PV<PE6DC*X,LEX@=FC.M>J2DA\9:;"AS@OU
M+,K:%,L>KNN9#Q*,>8NRPD@L1@WW!(-['M->)K:Q%O2SW4Y&>\Z5XU3.91CM
M?-)%+4(S$BT=33U<WKZA3UG\:J$9RY-UMDB3<%(.BL>JCJ[!*/^(+<W)BT %
M":<8IA9&<AB.W_(:+O% ,]=1, X=)Q2[Q(9T]O/XI'W&K5MO&,-_^"7'\!_^
M%</_E-V"7T:-:AS,B559Z)]T>,"4'].\[E-\^DFW'-BX9,H+U?."RQBU7R2E
M=XL!^Q_9E('*'SO2*A@HH($Y*M+Q:Q4(5'2AWPTWA&2FQ-25&5<FCU!;?KX*
MY;J^H/'JVIFO:SS:.<NUS"+@$?Q]NYIV&F^Z#->L;^5*&0R, OZ.N&PQK"M+
M4%U3IR<A5VOK'10CW*S&"Z,2%B[>2;>'KJ#C0.;"B-FV0R\,) M!"M:=HBQ:
M<'O:J(4JN:M,-<-<LEWU8=C78FR2D]G%.CC>7,V.7KV.:*WHSY67.@$.XL8J
M%LVFI_A P &9LXQA0(D*DA=H56!X[N-53$"Y(\X^?&AHH:5/G[)#4&TL"Q1
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M^8K^V1=;XF/..'TC#NB'U!:FG?;[];8^IW_DAQLC^1\'^G]02P$"% ,4
M" "]@;5:F,Z(#R,#  #6"P  $0              @ $     <')L8BTR,#(U
M,#4R,"YX<V102P$"% ,4    " "]@;5:)"[-C/P*  !_A@  %0
M    @ %2 P  <')L8BTR,#(U,#4R,%]L86(N>&UL4$L! A0#%     @ O8&U
M6BABUNE2!P  S%<  !4              ( !@0X  '!R;&(M,C R-3 U,C!?
M<')E+GAM;%!+ 0(4 Q0    ( +V!M5K;A(GR^BD  * O 0 2
M  "  086  !T;3(U,34W-C=D,5\X:RYH=&U02P$"% ,4    " "]@;5:;8MO
MJ5Y   #&>0$ %@              @ $P0   =&TR-3$U-S8W9#%?97@Q,"TQ
M+FAT;5!+ 0(4 Q0    ( +V!M5I"F,O2XPH  +TP   6              "
M <*   !T;3(U,34W-C=D,5]E>#$P+3,N:'1M4$L! A0#%     @ O8&U6C?[
MZ1;W5P  D[X! !8              ( !V8L  '1M,C4Q-3<V-V0Q7V5X,3 M
M-"YH=&U02P$"% ,4    " "]@;5:+;>I*K<2   C:   %@
M@ $$Y   =&TR-3$U-S8W9#%?97@Y.2TQ+FAT;5!+!08     "  ( !4"  #O
%]@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>tm2515767d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prlb-20250520.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001443669</identifier>
        </entity>
        <period>
            <startDate>2025-05-20</startDate>
            <endDate>2025-05-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-20" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-20" id="Fact000004">0001443669</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-20" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-20" id="Fact000010">2025-05-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-20" id="Fact000011">Proto Labs, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-20" id="Fact000012">MN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-20" id="Fact000013">001-35435</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-20" id="Fact000014">41-1939628</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-20" id="Fact000015">5540 Pioneer Creek Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-20" id="Fact000016">Maple Plain</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-20" id="Fact000017">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-20" id="Fact000018">55359</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-20" id="Fact000019">763</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-20" id="Fact000020">479-3680</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-20" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-20" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-20" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-20" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-05-20" id="Fact000025">Common Stock, Par Value $0.001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-20" id="Fact000026">PRLB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-20" id="Fact000027">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-20" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
